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Abstract
Cocaine and methamphetamine-addicted women are more likely to suffer from personal
life traumas that lead to persistent and committed drug abuse. In addition to socialpsychological problems associated with drug abuse are neuropsychological processes
involving specific regions of the brain responsible for working memory, decisionmaking, and impulse control. Classical and operant conditioning theories of learning
provide a paradigm foundation for this quantitative, correlational study that utilized
archival data from the National Institute on Drug Abuse (NIDA). I analyzed a randomly
selected sample of 186 adults who voluntarily participated in an eight-week treatment
program for cocaine and methamphetamine (MA) addiction. In my study, I found that
the level of participation in the eight-week treatment program was statistically significant
for women when compared to the level of participation for men; however, the level of
participation did not vary significantly by age, race/ethnicity or the Stroop Word Color
Task score (SWCT). I also concluded that to a statistically significant degree, women
experienced more of a participation drop-off than did men as the treatment program
progressed; however, participants’ attrition did not vary significantly by age,
race/ethnicity or SWCT score. Studies detailing neuropsychological experiences in
relationship to executive function in cocaine and MA-addicted women are not plentiful
and have not reached maximum significance in current research. It is expected that this
study will add to existing drug addiction studies and provoke greater interest in
neuropsychological experiences of women in all phases of addiction.
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Chapter 1: Introduction to the Study
Historically the abuse of cocaine and methamphetamine (MA) has been
categorized as largely a male phenomenon in the United States. Drug abuse researchers
conclude that the gender gap is narrowing as increasing numbers of females face lifethreatening risks related to drug addiction and addiction outcomes (Levandowski et al.,
2016; Pedraz, 2015). This chapter provides the following information: the study
background, the problem that was addressed, the purpose of the study, the research
questions and hypotheses, the theoretical framework, the nature of the study, the
definitions and assumptions, the research scope and delimitations, and the summary.
Cocaine and MA rank as two of the most addictive and abused stimulant drugs in
the world (United Nations Office on Drugs and Crime [UNODC], 2016). The United
States leads the world in the recreational use of cocaine, reporting well over 40% of all
consumption (Department of Justice [DOJ], 2015). North America, the world’s largest
cocaine market, has seen a steady rise in the expansion of the cocaine production and
distribution (UNODC, 2018). This report indicates that cocaine-related deaths in the
United States doubled between 2013 and 2016, from fewer than 5,000 to more than 10,
000 individuals. In addition, the illegal use of MA is exceeded only by that of marijuana,
with the United States ranked as 5th in the world for MA abuse (Center for Behavioral
Health Statistics and Quality [CBHSQ], 2015).
Although the abuse of cocaine and MA can produce serious consequences for any
use social, psychological and physiological effects appear to be more immediate,
enduring and destructive for female abusers (Clingan, Fisher, Pendersen, Reynolds, &
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Xandre, 2016; Shrestha, Huedo-Medina, & Copenhaver, 2015). Since early 2000, more
than 500,00 new cases of abuse or addiction have been reported annually among females
over the age of sixteen, although drug agencies estimate that the actual number of new
cases among female users is much higher (DOJ, 2015; National Institute on Drug Abuse
[NIDA], 2017; UNODC, 2018).
Psychological studies reveal that suicide attempts and suicide completions among
females are closely related to drug addiction. In their research, Dragisic, Dickov, Dickov,
and Mitjatovic (2015) found that among female substance abusers the risk of suicide was
6.5 to 9 times higher compared to nonaddicted women. Clingan et al. (2016) observed
that females addicted to cocaine and MA were more likely to engage in sexually criminal
activities (i.e. prostitution, pornography, sex trafficking etc.), thereby increasing the
likelihood of exposure to bodily harm, susceptibility to HIV/AIDS, and other sexually
transmitted diseases. Carson and Anderson (2016), in a report to United States
Department of Justice confirmed that the number of females incarcerated for drug-related
offenses surpassed these same offenses for incarcerated males. These reports indicated
that approximately 59% of females housed in federal prisons were convicted of drug
offenses compared with 49% of males who were convicted of similar offenses in 2015
(Carson & Anderson, 2016).
It is projected that there are more than 750,000 cocaine and MA exposed
pregnancies each year in the United States (NIDA, 2014). Studies of prenatal drug
contact indicate that children under the age of two exhibit a 50% higher risk of physical,
emotional, and neurocognitive impairments compared with children who were not
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prenatally subjected to drugs (Ballard, Weafer, Gallo, & de Wit, 2015; Du, Huang, Zhao,
& Hser, 2013). Pregnant women and care-giving mothers who abuse drugs can present
greater threats to the safety and well-being of their children than women who do not
abuse drugs (Ballard et al., 2015; Brogly, Link, & Newman, 2018).
Drug abuse and drug addiction are complicated processes involving numerous
psychological and physiological consequences. Among the most complex and
challenging processes of drug addiction are neurocognitive events that take place in the
brain of the abuser, producing dominant and long-term changes that can interrupt normal
neural functions (Bell, Garavan, & Foxe, 2014). Neuropsychological studies maintain
that while not all drug users will become addicted, users increase their risk of addiction
when specific regions of the brain evoke new patterns to accommodate drug introduction
(Becker, McClellan, & Reed, 2017). These studies are vital in that they offer insight
regarding special functions of the brain responsible for decision-making, working
memory and impulse control, all of which serve as predictors of continuing addiction
behaviors patterns in cocaine and MA-dependent individuals (Jasinka et al., 2014;
Moeller et al., 2014).
Neurocognitive studies involving tests of executive function reveal that while
cocaine and MA-addicted males and females exhibit similar problems in working
memory and decision-making tasks, stark differences between addicted males and
females emerge in tests of impulsivity (Moeller, 2014; Ray, 2013). In executive function
tests, females were more likely to demonstrate highly impulsive behaviors in responding
to drug use events compared with males. These impulsivity responses are also related to
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the likelihood of how females respond to drug treatment participation and completion
(Balconi et al., 2015; Jaskina et al., 2014).
Conducting pertinent psychological tests to assess executive function performance
can provide further insight in predicting treatment participation and treatment attrition of
substance-abusing females. One such test is the Stroop Word Color Task (SWCT), a
neuropsychological test used extensively in evaluating cognitive interference related to
executive function in drug addiction (Scarpina & Tagini, 2017). This study attempts to
add to existing knowledge by: (a) comparing how cocaine and MA-addicted people differ
by gender in their hours of participation in a treatment program; and (b) whether a
person’s degree of executive-function impairment is correlated with the person’s hours of
participation in a treatment program.
This study also supports professional practitioners in drug addiction evaluation
and treatment by providing further proof that diagnosis, treatment protocols, and
posttreatment assessment must include the significance of gender and neurocognitive
experiences. It is imperative that practitioners rigorously explore how specific brainbased behaviors in executive function among female addicts influences their ability to
successfully participate in drug treatment programs and avoid continued substance abuse.
Studies detailing neuropsychological experiences of adult female cocaine and MA
addiction are not plentiful in psychological literature and have not attained maximum
levels of diversity and inclusion. The implication in this study for positive social change
includes the necessity of eliminating gender-based stigmas and life-threatening
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vulnerabilities that often impede short- and long-term assistance for drug-addicted
women (Cockroft, Adams, Bonnet, Matlock, & Schlundt, 2019; Keane, 2017).
Background
Neuropsychological studies of the brain’s neural circuitry in substance abuse
indicate that women are more sensitive than men to the rewarding and motivational
effects of cocaine and MA. These same factors can propel prolonged drug abuse while
acting as strong deterrents in seeking treatment (Ballard et al., 2015). There is abundant
neuropsychological evidence that the prefrontal cortex (PFC) and associated circuits are
affected by cocaine and MA dependence (Kennedy et al., 2013; Pinel, 2011; Shrestha et
al., 2015). Anatomic studies of cocaine addiction identified the following changes in the
PFC: reduced gray matter, decreased white matter integrity, and increased white matter
intensities (Balconi & Finocchiaro, 2014; Ballard et al., 2015). Neuropsychological
researchers have indicated that decreased performance on executive function tests is
associated with impairment of prefrontal structures among cocaine abusers (Kober et al.,
2016). Researchers have substantiated that notable changes in the brain of the substance
abuser are causally related to the consumption and continued use of cocaine and MA.
Regardless of the stage of use (active consumption or abstinence), the user has no control
over neural circuitry changes, the duration of the effect, or new patterns of brain behavior
that might emerge (Ballard et al., 2015).
There is extensive confirmation that for cocaine and MA-abusing individuals,
prefrontal structures and functions dependent on PFC regions of the brain are different
compared with noncocaine and MA-abusing individuals (Balconi, et al., 2014; Nephew &
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Febo, 2012). In addition to localized brain behavior effects, cocaine and MA users
respond to environmental stimuli in the form of drug salience with attentional bias, a type
of involuntary attention and impaired working memory. Increases in working memory
demands are related to decreased performance on tests of cognitive control in female
substance abusers (Becker et al., 2017; Bickel et al., 2011; Simpson et al., 2016).
Clinical psychology researchers have strongly supported therapeutic drug
treatment programs in alleviating participant substance dependence; however, fewer than
half of participants complete recommended programs (Worhunsky et al., 2013). Female
participants with low attendance or high incompletion rates during active drug treatment
are more likely to return to substance abuse than program completers (FernandezMontalvo, Lopez-Goni, Azana, Arteaga, & Cacho, 2017). Neuropsychological evidence
found that the onset, maintenance and rehabilitation experiences of cocaine and MAaddicted individuals differ by sex; however, treatment outcomes are related to critical
areas of decision-making, planning, and impulsivity control are less well-known for
female addicts. These issues are problematic in that drug treatment success hinges, at
least in part on the amount of time a participant spends in treatment and, whether
participation is satisfactorily completed during a prescribed period.
In this research, I addressed gaps in the existing literature concerning drug
treatment participation and attrition (failure to complete treatment) in comparing cocaine
and MA-addicted females and males. In this study, I attempted to fill this void by
examining a test of executive function in conjunction with treatment participation of
cocaine and MA-addicted males and females enrolled in a drug treatment program.
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Given the multitude of problems faced by many cocaine and MA-addicted
women, more gender-based studies are needed to evaluate how executive function
processes (including impairments) might impact a woman’s level of participation in a
drug treatment program. The importance of furthering this research is connected to the
high-risk lifestyle of many addicted females and the need for intervention beyond
traditional treatment schemas (Fattore, 2015). Practitioners should work with other
professionals regarding improved initial treatment assessment, ongoing evaluation, and
follow-up in the posttreatment phase. Professionals must understand that due to the
criminal nature of illicit cocaine and MA use, abusers will often go to great lengths to
avoid detection; therefore, they may refuse any form of help that will expose them,
including seeking drug treatment (Barratt, Lenton, Maddox, & Allen, 2016; NIDA,
2017). Powerful negative social stigmas and stereotypes associated with drug abuse also
hinder efforts in identification, evaluation, and treatment for women (Adinoff et al., 2010;
Tull, Gratz, & Weiss, 2011).
Problem Statement
In this study, I explored a test of executive function, extent of participation in
drug treatment, and treatment attrition in a substance abuse treatment program for
cocaine and MA-addicted adult males and females. The Diagnostic and Statistical
Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association [APA],
2013) defines substance abuse as the frequent and often disruptive patterned use of drugs
evidenced by at least one significant event during a 12-month period in which an
individual is unable to fulfill a primary life role (APA, 2013).
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While there is little benefit for illegal drug use and substance abuse, the costs are
astronomical and negatively impact lives across every spectrum of society (National
Survey on Drug Use and Health, 2017). It is important to note that while much of the
recent emphasis on substance use and addiction has shifted to the growing opioid
epidemic in the United States, the abuse of cocaine and MA is viewed as a further
complication of opioid abuse (Economist, 2017; UNODC, 2016).
Completion of drug addiction treatment is one of the strongest indicators of
favorable rehabilitation and posttreatment abstinence; however, lower treatment
participation places females at higher risk for relapse and a deeper commitment to
substance abuse (Becker et al., 2017). These problems are often complicated by a lack of
access to affordable and comprehensive drug treatment programs, therefore reducing
positive therapeutic outcomes for cocaine and MA-addicted females (Becker, 2017;
NIDA, 2017).
Although it was not the goal of this study to identify specific drug abuse treatment
protocols, psychological researchers disclosed that gender disparities during all phases of
clinical intervention are more likely to produce negative long-term consequences for
addicted women compared with addicted men (Hagen et al., 2016). Drug abuse
researchers indicate that while cocaine addiction can present numerous struggles during
the treatment phase, MA addiction presents special hardships in that the abuse of MA is
often tied to group behavior; therefore, posttreatment success is highly dependent upon
breaking group cooperation and drug-reinforcing relationships (Lester & Lagasse, 2010;
NIDA, 2017).
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Neuropsychological researchers determined that interruptions in normal brain
functions of substance-abusing females include problems with speech-language patterns,
decision-making, strategic planning, behavior inhibition, and impulsivity control (Balconi
et al., 2015; Fridberg, Gerst, & Finn, 2013; Levandowski et al., 2016; Luo et al., 2013).
Drug addiction researchers indicated that specific brain activations induced by exposure
to drugs increase female substance vulnerabilities to habitual use (Balconi et al., 2015;
Du et al., 2013; Everitt, 2014; Quinones-Jenab, & Jenab, 2012). Neurocognitive
processes and drug treatment outcomes specific to female cocaine and MA abusers
remain relatively unexplored aspects of drug abuse. This omission represented a major
gap in the literature as substantiated by current research findings that treatment
participation is positively correlated to executive function deficits (Du, Zhao & Hser,
2013; Everitt, 2014; Shrestha et al., 2015).
Executive function impairments in the brain are strongly associated with
neurocognitive interference in individuals, which in turn has been linked to treatment
attrition and relapse behaviors (Ballard et al., 2015; Morie, De Sanctis, Garavan & Foxe,
2014). Neuropsychological tests reveal that female cocaine and MA abusers are more
likely to experience neurocognitive interference in processing congruent and incongruent
task stimuli compared with addicted males (Kennedy, Epstein, Phillips, & Preston, 2013;
Mitchell & Potenza, 2015).
Cocaine and MA dependence involves various networks of neurocognitive
patterns that can lead to serious neuropsychological deficits and executive functioning
impairments (Ballard et al., 2015; Ide, Zhang, Hu, Mazure, & Li, 2014). Researchers

10

examining executive function patterns have demonstrated that cue-conditioned reactivity
propels impulse cravings and continued drug-seeking behavior in cocaine and MAaddicted females (Clingan et al., 2016; Moreno-Lopez, Stamatakis, Fernanado-Serrano,
Gomez-Rio, & Verdejo-Garcia, 2012; Volkow et al., 2011). Neurocognitive events
associated with executive function interruptions are extremely useful in explaining how
cocaine and MA reactive cues influence regional metabolic changes in females more so
than in addicted males (Kornreich et al., 2012; Luo et al., 2013).
Volkow and Tomasi (2011a) found gender differences in brain reactivity events
that were supported in the following ways: (a) cocaine and MA use in females affected a
larger portion of the female’s brain and, (b) cocaine and MA cues were significantly
stronger in females than in males as revealed in tests of neural changes in brain glucose
metabolism rates. In addition, these researchers established that neural system processes
associated with neurocognitive functions were not similar for males and females, and
therefore required further investigation. Van der Plas, Crone, van den Wildenberg,
Tranel, and Bechara (2009) compared the performance of 133 alcohol, cocaine, and MAdependent males and females with healthy controls on complex decision-making,
working memory, and neurocognitive flexibility tasks. They concluded that decisionmaking abilities were significantly more impaired in female addicts than in male addicts,
especially in tasks requiring high levels of cognition and impulse control. Neurocognitive
studies represent an important aspect of female drug addiction; however, significant gaps
remain in terms of explaining how and why neurocognitive pathways of drug addiction
can lead to very different therapeutic outcomes for women compared with male addicts.
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Purpose of the Study
This quantitative, correlational research method examined whether the level of
attendance and attrition of cocaine and MA-addicted participants in a substance abuse
treatment program is associated with the participants’ demographic characteristics and
the participants’ performance on a test of executive function. A quantitative,
correlational research design is appropriate because this study analyzes relationships
between two or more variables that can be quantified (Gregory, 2011).
In this study, there are four independent variables: (a) participants’ performance
on the SWCT, (b) participants’ gender, (c) participants’ age, and (d) participants’
race/ethnicity. There are two dependent variables: (a) the total number of hours of
treatment received during the eight-week period, and (b) the differential between the
number of hours of treatment received during the first four weeks and the number of
hours of treatment received during the last four weeks. The second measure was
included to address the issue of participant attrition. Multiple regression analysis was
used to examine: (a) the relationship between the four independent variables and the first
dependent variable, and (b) the relationship between the four independent variables and
the second dependent variable. The SPSS statistical software program and NIDA
codebook were utilized in analyzing the data.
Research Questions and Hypotheses
This study addressed the following research questions and hypotheses, using a
randomly selected sample of 186 addicted individuals:
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Research Question 1: Does the Stroop Word Color Task (SWCT) predict the level
of participation when controlling for all other variables?
H01: The SWCT does not significantly predict the level of participation when
controlling for all other variables.
Ha1: The SWCT significantly predicts the level of participation when controlling
for all other variables.
Research Question 2: Does gender predict the level of participation when
controlling for all other variables?
H02: Gender does not significantly predict the level of participation when
controlling for all other variables.
Ha2: Gender significantly predicts the level of participation when controlling for
all other variables.
Research Question 3: Does age predict the level of participation when controlling
for all other variables?
H03: Age does not significantly predict the level of participation when controlling
for all other variables.
Ha3: Age significantly predicts the level of participation when controlling for all
other variables.
Research Question 4: Does race/ethnicity predict the level of participation when
controlling for all other variables?
H04: Race/ethnicity does not significantly predict the level of participation when
controlling for all other variables.
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Ha4: Race/ethnicity significantly predicts the level of participation when
controlling for all other variables.
Research Question 5: Does the SWCT predict the level of attrition in participation
when controlling for all other variables?
H05: The SWCT does not significantly predict the level of attrition in
participation when controlling for all other variables.
Ha5: The SWCT significantly predicts the level of attrition in participation when
controlling for all other variables.
Research Question 6: Does gender predict the level of attrition in participation
when controlling for all other variables?
H06: Gender does not significantly predict the level of attrition in participation
when controlling for all other variables.
Ha6: Gender significantly predicts the level of attrition in participation when
controlling for all other variables
Research Question 7: Does age predict the level of attrition in participation when
controlling for all other variables?
H07: Age does not significantly predict the level of attrition in participation when
controlling for all other variables.
Ha7: Age significantly predicts the level of attrition in participation when
controlling for all other variables
Research Question 8: Does race/ethnicity predict the level of attrition in
participation when controlling for all other variables?
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H08: Race/ethnicity does not significantly predict the level of attrition in
participation when controlling for all other variables.
Ha8: Race/ethnicity significantly predicts the level of attrition in participation
when controlling for all other variables.
Theoretical Foundation
In my study, I utilized two theoretical models of learning, classical and operant
conditioning. Classical (Pavlovian) and operant (Instrumental) conditioning learning
theories support the view that neuroadaptations of brain systems affected by illicit drugs
subsequently produce conflicting events (tolerance as well as avoidance behavior) in
male and female addicts (Everitt, 2014; Yager & Robinson, 2014).
Major theoretical propositions of both classical and operant learning in this
addiction study are predicated on the following assumptions: (a) brain behaviors in
addiction are contingent on conditioned associations in terms of initial and continued
drug use for female and male addicts, and (b) cognitive and executive function
impairment associated with positive and negative reinforcement attributes differ by
gender in drug treatment and posttreatment relapse (Kober et al., 2016). These
psychological models of learning suggest that brain activation processes responsible for
mapping drug patterns, including impulse, motivation, and neurocognitive functions, are
different in female addicts compared with male addicts (Becker, Perry, & Westenbroek,
2012; Kerstetter, Zu-in, Ettenberg, & Kippin, 2013; Mahoney, Hawkina, De LaGarza,
Kalechstein, & Newton, 2010).
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Studies involving neurocognitive processes and gender have demonstrated that
significant differences exist between males and females, particularly in cue-conditioned
reactivity and drug reward mechanisms with females exhibiting stronger and more
enduring drug cue associations than for addicted males (Moreno-Lopez et al., 2012;
Nephew & Febo, 2012; Volkow et al., 2011b). In the realm of executive function these
differences are especially problematic because impaired decision-making, learning
deficits, and poor impulse control are the very mechanisms that impede successful
treatment and encourage relapse to drug-seeking behaviors in female addicts (Becker,
McClellan, & Reed, 2016; Kornreich et al., 2012; Luo et al., 2013).
The research questions and hypotheses in this study are predicated on a
neuropsychological test of executive function performance among cocaine and MAaddicted males and females. In addition, researchers have demonstrated that executive
impairments influence treatment attendance and attrition rates differently by gender (Bell,
et al., 2014; Luo et al., 2013; Woicik et al., 2011). Classical and Operant conditioning
theories of learning are discussed in more detail in Chapter 2.
Nature of the Study
In this study, I examined the level of participation among 186 randomly selected
cocaine and MA-addicted men and women enrolled in an eight-week drug treatment
program. Multiple regression analysis was used to investigate whether the level of
participation varied, in a statistically significant manner, according to a participant’s
executive-function capability and a participant’s gender, age and race/ethnicity. A
quantitative, correlational method of analysis, such as multiple regression is appropriate
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for assessing the potential relationship between two or more variables measured for
members of a group (Gregory, 2011). The research design used in this study was deemed
appropriate for secondary data analysis in which new theoretical questions were formed
from an existing study population (Creswell, 2009).
Definitions
Classical learning theory: Ivan Pavlov’s theory of learning associated with
classical conditioning as a reflexive or automatic type of learning in which a stimulus (S)
acquires the capacity to evoke a response (R) that was originally evoked by another
stimulus (Flagel, Akil, & Robinson, 2009).
Cocaine and methamphetamine abuse/addiction: The Diagnostic and Statistical
Manual of Mental Disorders (5th ed.; DSM-5; APA, 2013) defines substance abuse as the
frequent and often disruptive patterned use of drugs evidenced by at least one significant
event during a twelve month period in which an individual is unable to fulfill a primary
life role (APA, 2013).
Comalli-Kaplan Version of the Stroop Word Color Task: The Comalli-Kaplan
version of the SWCT comprises three subsections designed to assess a subject’s ability to
suppress interfering stimuli. These tasks are contained on three stimulus card sets, each
containing 100 stimuli (Strauss et al., 2005). This version is relevant to the present study
because modifications of this task require that the color naming card be presented first,
that errors are recorded, and that allowances are made for self-correction of errors before
moving on to the next stimuli (Strauss et al., 2005; Winhusen 2013). These test
modifications serve two purposes in neurocognitive function and drug addiction studies:
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(a) individuals who are color-blind will be quickly identified, and (b) this test procedure
maximizes the interference effect by presenting the word condition just prior to the
interference task (Strauss et al., 2005).
Executive function (cognitive interference): Defined as the frontal area of the
brain, including the stratum, prefrontal cortex, anterior cingulate cortex and amygdala,
and largely responsible for learning, memory, complex decision-making, complex task
execution, ability to control impulses and other critical information processes (Herbeck &
Brecht, 2013).
Operant conditioning theory: B.F. Skinner’s theory of learning based on the idea
that learning is a function of change in overt behavior. Changes in behavior are the result
of an individual’s response to events (stimuli) that occurs in the environment and
produces a consequence because of that response (Flagel, Akil, & Robinson, 2009).
Length of treatment participation: Defined as the total number of hours of
treatment received during the eight-week treatment program.
Treatment attrition: Defined as the differential between the number of hours of
treatment received during the first four weeks of the eight-week treatment program and
the number of hours of treatment received during the last four weeks.
Assumptions
Assumptions in this study include the following: (a) that the participants in the
archival study met all requirements in terms of eligibility and provided honest answers
regarding their active use of cocaine and MA while enrolled in the eight-week drug
treatment program; (b) that all treatment program participation was voluntary, that there
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was no “hostile” or “coercive” participation involved, and that participation was not
court-ordered or otherwise mandated; (c) that the participants’ responses in completing
the SWCT were accurately recorded; and (d) that the number of hours of participant
attendance in the eight-week treatment program was accurately recorded. I assumed that
the subjects understood questions that were asked in all phases of the archival study.
These assumptions are necessary in the context of this research because the requirement
that all eligible participants provide truthful answers regarding their current drug use
status is paramount to their acceptance in an 8-week substance use treatment program. It
was also important that all phases of program participation are completely voluntary and
without duress because “forced” participation can create a “hostile” environment toward
staff and other participants, thereby threatening study validity.
Scope and Delimitations
In this research, I investigated whether the level of attendance and attrition of
cocaine and MA-addicted participants in an 8-week drug abuse treatment program was
associated with participant’s performance on a test of executive function. This specific
aspect was chosen because I wanted to determine whether treatment program
participation and attrition differ by gender, age, or race/ethnicity of a participant. In
addition, I was interested in whether performance on a test of executive function is
associated with a participant’s attendance in the specified treatment program.
In the CTN-0031A study, 186 participants were deemed eligible for participation.
It was expected that this research would have limited generalizability in that all
participants were active cocaine and MA-addicted individuals, therefore representing a
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much smaller portion of the general adult population in the United States. In my study,
there were 61 male participants compared to 145 female participants, constricting my
ability to draw conclusions about male addicts as a subgroup. Although this was a
randomly selected sample of adult males and females, there remained possible threats to
internal validity in terms of rate of attrition due to unknown factors associated with a
participant’s late entrance or early exit from the treatment program. The ability to
generalize study results to those who do not complete versus completers of the treatment
program study was an external validity issue. In both cases, internal and external validity
issues were addressed.
Limitations
My research most notably had several limitations. In the archival study, six
psychometric tests were evaluated; in this study only one psychometric test, the SWCT,
was assessed. It is possible that one or more of the missing psychometric tests would
demonstrate a stronger association of executive function and treatment participation than
the SWCT. Also, the ability of psychometric tests to predict functional behaviors can be
problematic due to the presence of confounding or unknown variables (Gregory, 2011).
Psychometric tests, including the SWCT, present special challenges because a situation is
structured in which a participant must demonstrate proficiency in reasoning, planning and
flexibility on a variety of timed tests. In formal testing, the examiner determines
participation eligibility, which materials are employed, where and how testing takes
place, duration of tests and how performance on tests is documented (Gregory, 2011). In
the archival study, issues of possible selection bias and researcher bias were addressed to
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ensure that study participants were able to fully understand instructions and were able to
complete the SWCT using computer-based aids.
Significance of the Study
Neuropsychological researchers have demonstrated that women experience
unique challenges in terms of onset, maintenance and recovery from cocaine and MA Pe
addiction (Peters, Guille & Mitttal, 2019). In this study, several reasonable measures
were reserved to address limitations including understanding limited generalizability and
the uniqueness of the study population. The importance of understanding problems of
female addiction is relevant not only for identification and assistance in recovery but also
for evaluating and documenting measurable progress in rehabilitation efforts. Success in
recovery is highly correlated with consistent and comprehensive levels of drug treatment,
and ongoing posttreatment program support (Becker et al., 2017).
In this research I explored associated neural processes of addiction unique to
women, and how those processes can impact their recovery or prolong their commitment
to drug addiction. I also sought to underscore the relevance of executive function
impairments and treatment participation among male and female cocaine and MA
addicts. I anticipated that this research would further promote universal awareness and
intervention in addiction treatment programs for women. In my study, I expected that in
examining levels of participation, attrition and performance on a test of executive
function would yield new knowledge thus reinforces the importance of additional studies
of adult female cocaine and MA addicts. The implications for positive social change
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included the recognition that female drug addiction must be given the same priority as
any other problem associated with women’s health and wellness.
Summary
Neuropsychological researchers have indicated that executive function deficits are
more persistent and life-threatening in cocaine and methamphetamine (MA) addicted
females compared with addicted males (Fattore, 2015; Hurtado et al., 2016). Neural
processes connected to initial use, maintenance and treatment relapse vulnerability have
received increasing empirical support, but the role of executive function and gender in
drug addiction is less clear (McHugh et al., 2017). Impairments related to executive
functions are viewed as high vulnerabilities in terms of identification and screening of
abuse, lower treatment participation and a return to drug use pose continued long-term
risks of drug use for cocaine and MA-addicted females. This chapter provided: (a) an
overview of the association between gender and neurocognitive processes in cocaine and
MA addiction; (b) the assumptions, scope and delimitations of the study; and (c) the
significance of the study.
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Chapter 2: Literature Review
Neuropsychological studies of neurocognitive deficits related to cocaine and MA
abuse have demonstrated that vulnerabilities, treatment and relapse differ by sex
(Bobzean et al., 2014; Fattore et al., 2014; Kennedy et al., 2013; Ramackers et al., 2016).
Recently, NIDA (2017) indicated that abuse and dependence on cocaine and MA has
risen significantly among women in the United States. Researchers studying
psychological aspects of drug addiction have determined that the experiences of women
during drug-seeking, abstinence and relapse stages differ drastically from the experiences
of drug-addicted men. In addition, researchers have indicated that women addicted to
cocaine and MA may be more prone to developing harmful changes in brain structures
related to cognitive and executive function than stimulant-addicted men (Becker et al.,
2012; Kerstetter, Zu-in, Ettenberg, & Kippin, 2013; Winhusen et al., 2013).
Researchers conducting neuropsychological studies employ multiple
terminologies in defining drug addiction including the terms “substance use disorder” and
“substance abuse” (Gould, 2010). The generally accepted definition of drug addiction is
a “chronic, relapsing brain disease that is characterized by compulsive drug-seeking and
use, despite harmful consequences” (http://www.drugabuse.gov). Addiction researchers
define drug addiction in this manner because addiction can interrupt, reconfigure, and
modify critical structures in the brain (Pinel, 2011). Researchers maintained that changes
in the brain can have adverse short and long-term consequences that often result in
dangerous and self-destructive behaviors that can subsequently lead to irreversible brain
damage, harm, or death (NIDA, 2013; Pinel, 2011).
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Executive functions are those brain functions involved in complex cognitions
such as solving novel problems, modifying behavior, considering new information,
generating strategies, or sequencing complex actions (Eisinger, Larson, Boulware,
Thomas, & Mermelsten, 2018). Executive function tests have also been used to predict
differential rates of attrition of female drug abusers compared with male drug abusers
(Goldstein & Volkow, 2011; Najavits & Lester, 2008; Marceau, Kelly, & Solowij, 2018).
Executive systems coordinate, control, and assist in neural processes of goal-orientation
in learning and decision-making (Hart, Marvin, Silver, & Smith, 2012; Potenza et al.,
2012).
Drug addiction researchers in examining drug-seeking and drug maintenance
behaviors concluded that addictive behaviors are not “normal” occurrences that simply
happen at the will of the abuser. Drug addiction is often complicated by a constant need
for secrecy, risk-taking, and openly hostile societal stigmas; thus, the reward of the drug’s
affect must have more importance to an abuser than the threats involved in drug use
(Barrett et al., 2016; Everitt, 2014; NIDA, 2017). Cocaine and MA addiction can have
noticeably detrimental effects on women’s decision making and critical thinking
processes (Mehrjerdi et al., 2010). The significance of these impairments in neural
systems are also implicated in the increasingly risky, violent and often life-threatening
behaviors that drive women to continue drug abuse (Becker, 2012; Bisagno & Cadet,
2014; NIDA, 2014). In this study I examined whether the level of attendance and
attrition for cocaine and MA-addicted males and females was associated with the
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participants’ demographic characteristics and the participants’ performance on a test of
executive function.
This chapter begins with a comprehensive review of the literatures of classical
and operant conditioning theories of cocaine and MA addiction specific to gender. Next,
a survey regarding research about the neurochemistry of cocaine and MA relevant to this
study is provided. Subsequent sections offer an in-depth examination of literatures that
explore the connection between neuropsychological processes of cocaine and MA
addiction and gender differences. In addition, relevant studies of cognitive and executive
function related to neuropsychological performance and gender are examined. The
literature review concludes by focusing on research evidence that supports the need for
more empirical studies concentrating on all aspects of the psychological experiences of
cocaine and MA addiction in women.
Literature Search Strategy
A thorough review of the literatures for this study was acquired by examining
secondary sources published between 2007 to the present. The terms used to find
information for this study include, but are not limited to, the following: addiction,
substance use, substance abuse, cocaine, methamphetamine, neurocognitive interference,
cognition, executive function, gender, sex, learning and memory, neuropsychology,
neurocognition, neuroscience, and neuropsychological tests. Material for the literatures
was obtained from the following databases: EBSCOHOST, MEDLINE, NCBI, NIDA,
and PSYCHINFO. Additional information was found on internet sites developed by
well-regarded organizations, including the American Psychological Association (APA),
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Center for Behavioral Health Statistics and Quality (CBHSQ), Centers for Disease
Control (CDC), Department of Justice (DOJ), National Institutes of Health (NIH),
European Monitoring Center for Drugs and Addiction (EMCDA), National Center for
Biotechnology (NCBI), and the Walden University Library.
Theoretical Foundation
Classical (Pavlovian) and Operant (Instrumental) conditioning theories of learning
support the view that neuroadaptations of brain systems affected by illicit drug use
subsequently produce conflicting events, a desire to tolerate drugs while seeking
avoidance of the same (Everitt, 2014; Yager & Robinson, 2014). The rationale for
examining drug addiction models in relationship to classical and operant conditioning is
relevant for two important reasons: (a) brain behaviors in addiction are contingent on
conditioned associations of drug-seeking and drug-taking activities; and (b) executive
function impairment is predicated on positive and negative reinforcements in addiction
onset, treatment and avoidance.
Classical Conditioning Theory
Ivan Pavlov’s work with animals in classical conditioning and learning provides
compelling evidence that an event paired with a stimulus can predict future behaviors
based on previous experience (Milton & Everitt, 2012; Jasinska et al., 2014; Pinel, 2011).
Milton and Everitt (2012) contend that in both drug-seeking and drug-taking behaviors,
“Pavlovian or non-contingent behavior (stimulus-response) occurs with extensive training
associations between the drug-conditioned stimulus and of drug-seeking and taking
(stimulus-response actions or S-R associations” (p. 1120). Hence, through Pavlovian
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conditioning, drug-associated stimuli become wanted and preferred, grab attention and
produce a variety of physiological and psychological responses in the user (Goddard et
al., 2013). Should this cycle continue unchecked in the user, drug-taking can move
beyond voluntary to involuntary; this process becomes the transitory mechanism in
forming new brain behavior associations leading to drug addiction (Goddard et al., 2013).
Classical conditioning in animal studies involving drug-seeking tasks have
demonstrated that dependence vulnerability is clearly connected to cocaine and MArelated cues rather than solely pharmacological effects; thus, inferring that when these
cues are no longer present, drug-seeking is significantly reduced and only recurs when
these cues are re-introduced ( Lejuez et al., 2007; Koob & Volkow, 2010). Addiction
theorists contend that while any user is susceptible to progressive drug use after initial
administration, there are some notable differences in how drug-seeking behaviors,
frequency and reward mechanisms deviate in terms of gender (Zuloaga et al., 2015).
Studies of substance abuse also underscore that women are more prone to develop cueinduced drug cravings and therefore more likely to relapse into cycles of chronic
dependence compared with male addicts (Kerstetter et al., 2013; Potenza et al., 2012). In
this respect, the continued response to cocaine or MA stimuli reinforces the probability of
repeating drug-seeking and drug-taking behaviors (Dalla & Shors, 2009; Milton &
Everitt, 2012).
Volkow et al. (2011b) used Positron Emission Tomography (PET) to compare
brain metabolism among female and male cocaine addicts. Their study hypothesized that
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females would demonstrate greater reactivity when presented with various drug cues, and
that distinction could explain their high probability to relapse.
Although these researchers found that men and women who viewed cocaine-cued
videos did not differ by gender in self-reported drug cravings, gender differences in brain
metabolism were observed. Female subjects exhibited decreased metabolism, whereas
metabolic rates increased among male participants. As with other PET studies of cueconditioning and gender, this research confirmed that gender differences exist in
vulnerabilities to continued drug use and in relapse susceptibility (Andersen et al., 2012;
Potenza et al., 2012; Volkow et al., 2011). In neuroimaging studies, classical
conditioning research proposes that a stronger motivation for continued drug-seeking and
drug-taking action occurs because the brain regions responsible for reinforcing substance
abuse are the same systems that are most resistant to drug abstinence (Mitchell &
Potenza, 2015; Balconi & Finocchaiaro, 2015).
A major premise in classical conditioned response research is that if drug cues are
not available, then drug-seeking actions are radically lowered; however, once drug cues
are reinstated, drug-seeking behaviors are renewed (Goddard, 2013; Ramoa et al., 2013).
Classical conditioning animal research suggests that long-term drug abuse leads to
adverse changes in the PFC neuronal structure producing modified functional activation
of the orbito-frontal cortex oPFC in cocaine addicts (Everitt, 2014). Pre-Frontal Cortex
and oPFC changes may also influence long-term “recovery effects on drug-taking and
drug-seeking behaviors” (Everitt, 2014, p. 132).
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Conditioning models demonstrate the complexities of neuropsychological
processes in female addiction. The processes include drug susceptibilities and repetitive
relapse behaviors that can occur even after an extended absence of drug-taking (Kennedy
et al., 2013; Najavits et al., 2008; Ramoa et al., 2013). Although neural response studies
have been more inclusive of the experiences of female addicts, previous research has
failed to determine the strength of associations between stress, drug cues and craving
among women (Potenza et al., 2012). To further illustrate gender differences in
relationship to stressors and drug-induced cravings, Potenza et al. (2012) employed
Functional MRI (fMRI) imaging to evaluate individualized script responses using stress,
drug/alcohol cues and neural-relaxing imagery conditions in 30 abstinent cocainedependent men and women. This group was compared with 36 healthy (sporadic
drinking) participants. Functional MRI results revealed prominent three-way
communications visible in several brain regions including “the striatum, insula, and the
anterior and posterior cingulate” (p. 406). From this study, these researchers determined
that while drug-induced craving cues were positively associated with increased
corticostriatal-limbic brain activity in both male and female participants; females
experienced significantly greater hyperactivity in this region of the brain when stressinducing cues were introduced compared with cocaine-dependent males.
Similar studies suggest that corticostriatal-limbic hyperactivity appears to be
linked to stress cues in women, drug cues in men, and neural-relaxation conditions in
both (Gallop et al., 2007; Ide et al., 2014). Cocaine and MA-addicted females were more
likely to link daily stress and unresolved psychological problems as sufficient motivators
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to continue risky and even criminal activities (i.e. sex trading, stealing, assault etc.) in
drug-seeking and drug-taking (Moeller et al., 2010; Tolliver et al., 2012; Tull et al.,
2011). In their studies of cocaine-dependent individuals, Mahoney et al. (2010) found
that women report more psychotic symptoms, including paranoid and grand delusions,
perceptual disturbances and auditory episodes, tactile and olfactory hallucinations more
frequently than men. These findings are consistent with other psychological studies
hypothesizing that increases in psychotic symptoms reported by adult females increased
drug quantities per day and for longer periods than for addicted adult males (Anker &
Carroll, 2011; Fox et al., 2014; Volkow et al., 2011a). Classical conditioning theory
relates to the archival study in that the behaviors associated with continued drug use or
avoidance are related to learned brain behaviors among addicted individuals.
Contemporary drug addiction theories concur that neurocognitive paths to addiction
reinforce continued patterns of use or new learning that helps the individual to avoid or
break these habits (Yager & Robinson, 2014).
Operant Conditioning Theory
The chief motivation for drug-seeking behavior in laboratory animals is
associated with behaviors that produce positive outcomes (the reduction of pain and
hunger). These motivational behavior processes are similar in humans (Gould, 2010).
While Pavlov’s classical conditioning studies offer some explanation of the cueconditioning and reward process in drug abuse behaviors, it does not fully explain why
behaviors continue even when associated actions can cause irreversible harm to the user
or others. Operant (instrumental) conditioning originates from the work of E.L.
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Thorndike who theorized that conditioning in learning depends upon the consequences of
an action to modify the likelihood of that same action occurring in the future (Milton &
Everitt, 2012). Thorndike’s claim that conditioning in learning depends on the
consequences of an individual’s actions differs from Pavlovian conditioning in which
“contingency between the CS (conditioned stimulus) and US (unconditioned stimulus) is
dependent on the individual’s behavior” (Milton & Everitt, 2012, p. 1123). In this
regard, the motivation to continue the instrumental response relies on whether the action
results in a positive or negative consequence (Milton & Everitt, 2012).
In congruence with classical conditioning, instrumental conditioning supports the
power of reinforcing mechanisms that involve the dopamine and limbic systems creating
new patterns of learning and memory (Nyberg, 2012). These neural systems deliver the
“rewarding effects of drug use” (positive reinforcement), thus inciting little incentive for
the drug abuser to avoid continued drug use. Despite the desire of an individual to
abandon these behaviors, ceasing cocaine and MA use can bring on severe and painful
withdrawal symptoms, thereby sustaining patterns of drug administration and avoidance
of treatment (Milton & Everitt, 2012; Pinel, 2011). Due to the strength of these potent
reinforcing drug cues, Koob & Volkow (2010) note that the ingestion of stimulant drugs
can overpower the body’s natural rewards for eating, drinking, and sexual activity, thus
altering the satisfaction of these rewards.
Over time, neglect or abstention of the body’s natural rewards can diminish to
dangerous levels, leaving the drug abuser at greater risk for more drug-seeking in
attempts to satisfy an increasing need for “drug-induced rewards” (Volkow et al., 2015).
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Neuropsychological learning and conditioning response processes associated with these
behaviors have been examined using laboratory animals (Pinel, 2011). Researchers
found that the animals learned to self-administer all drug types except for LSD (Everitt,
2014). These findings support the hypothesis that conditioning in drug-seeking cues in
laboratory animals are greatly influenced by motivation and reward, much like drugseeking in humans is motivated by reward processes (Gould, 2010; Moeller et al., 2014;
Todd, Vubric, & Bouton, 2014). New behaviors that result from reward processes due to
repeated patterns are categorized as positive reinforcement (Gould, 2010).
In experimental settings, laboratory animals learn to press a level to obtain food,
or a dog follows verbal commands to obtain a treat (Gould, 2010). Once this behavior is
positively reinforced (obtaining a treat with each correct response) the behavior is likely
to continue regardless of new tasks that might be added to obtain “the reward” (Gould,
2010). When drug-seeking behaviors are “rewarded” in the abuser, the desire to continue
this positively reinforcing behavior is likely to persist even when new obstacles are added
(i.e. family dysfunction, loss of employment, homelessness, court-ordered drug
treatment, incarceration etc.). Conditioned learning models refer to “motivation” as an
important impetus in drug abuse; it is this motivation that perpetuates avoidance in
seeking help and perpetuates a cycle of relapse (Gould, 2010; Milton & Everitt, 2012;
Fox et al., 2014).
An increasing dependence on drugs wakens motivational systems in this realm of
human behavior; the drug is the “cue” or “reward” and the repetition of drug use links the
association between the cue and response; thus “rewards” experienced by the user
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become stronger upon successive administration (Milton & Everitt, 2012). Carey et al.
(2014) suggest that this model of addiction can be viewed in terms of special paths that
involve the development of habitual behavior patterns independent of cognitive
processes. Neural transmitters relaying constant messages to the PFC centers of the brain
to continue addictive behaviors can prove so robust that impulses associated with selfrestraint in drug-seeking and drug-taking are no longer under the control of the drug user
(Carey et al., 2014).
Literature Review Related to Key Variables and/or Concepts
Mahoney et al. (2010) found that continued abuse of cocaine and MA can lead to
the onset of psychotic symptoms. Active cocaine and MA participants responded to
survey questions from the Psychotic Symptom Assessment Scale, which listed an
assortment of psychotic symptoms experienced during drug use (Mahoney et al., 2010).
These researchers concluded that in the “while abstinent” phase, cocaine-addicted women
reported experiencing auditory hallucinations more frequently, while men expressed
delusions of grandeur. Among MA addicts, in the “while abstinent” phase, women were
more likely than men to report that they experienced severe body image distortions
(Mahoney et al., 2010). In each group (whether MA or cocaine) all users reported
various psychotic symptoms (auditory and olfactory hallucinations) as being more intense
in the “while high” stages of drug use (Mahoney et al., 2010).
Cocaine-dependent women often experience heightened vulnerabilities to social,
physical and psychological consequences of substance use, which can encourage a return
to use if strong social supports are not available (Winhusen et al., 2013b). Cocaine-
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addicted women also differ from similarly dependent men in their neural response to cueinduced cravings and stress (Mahoney et al., 2010; Mitchell & Potenza, 2015). In a study
of gender and MA abuse, Zuloaga et al. (2015) proposed that alterations in the
hypothalamic-pituitary-adrenal axis can propel repeated drug abuse, not for the desired
“high” but rather to counter the worsening levels of stress and anxiety induced when the
effects of the drug were no longer present. In substance-abusing pregnant women these
events are especially problematic in that stress-induced cortisol levels were significantly
higher in MA exposed infants than in those who had not been exposed to MA (Zuloaga et
al., 2015).
Complicating the cyclical nature of chronic drug abuse in women, especially
among those in drug treatment, are the numerous factors involved in drug-seeking and
new problems that arise when women move from drug experimentation to full addiction.
Studies in cue association in classical and operant conditioning support other research
findings that consistency in activation of the amygdala and Ant Cing in female addicts
when exposed to drug cues, increases episodes of drug craving (Colzato et al., 2009;
Ersche et al., 2006; Pinel, 2011). Operant conditioning theory is relevant to the archival
study in terms of the long-documented associations between positive and negative
reinforcement of persistent drug addiction behaviors. Pinel (2011) argued that
motivational processes and consequences of actions are connected to the continuation of
addiction cycles or the motivation to cease repeating these patterns.
Approaches, strengths, and weaknesses of drug addiction research. Previous
studies of cocaine and methamphetamine addiction (MA) have been subsumed under the
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auspices of general drug addiction and typically included few (if any) female substance
abusers (Becker et al., 2017). Two major psychological approaches are discussed in terms
of their contributions, strengths and weaknesses in female drug addiction. In those
studies that focused on brain functions with an expressed interest on neurocognitive and
executive function, there was more of an effort to include sex related similarities and
differences in long-term cocaine and MA addiction. The strength of neuroimaging
technology studies has added significant value to the discipline of psychology in terms of
revealing the relevancy of this research in addiction related brain circuits and behavioral
outcomes as well as tendencies to relapse. Neuroimaging and PET (Positron Emission
Technology) studies have added to drug addiction literatures in that the neuroscience
advances in brain-based behavior in drug addiction by examining actual brain pattern
differences between female and male addicts. Neuroimaging research has become
increasingly valuable in untangling the complications of associations between brain
reward and neurocognitive functions related to the onset, maintenance and treatment of
addiction in women and men (Ballard et al., 2015).
Theory-based studies of drug addiction, including classical and operant
conditioning theory, emphasize the power of brain-based behaviors in terms of
conditioning and the power of “rewards” or “punishment” in drug-seeking and drugtaking behavior. These studies also underscore the ranking of individual cue reactivity in
drug addiction but also confirm the power of external forces in shaping these behaviors
(Volkow et al., 2015). Both approaches contribute to the general understanding of drug
addiction among males and females; however, neither approach has comprehensively
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included narratives of adult female experiences. Little justification has been provided
concerning the omission or marginalization of female participants in neuroscience studies
of drug addiction. In addition, the stigma of female drug abuse (even in scientific
research) has delayed critical examination of sex differences in neurocognitive studies of
brain-based behaviors in drug addiction.
Justification of concepts. Based on current cocaine and MA addiction studies in
which adult females more fully participate, there is a growing area of psychological
research that supports sex differences in terms of onset, maintenance and treatment
success (Fernandez-Montalvo et al., 2017; Keane, 2017). Researchers found that drug
treatment program success appeared to be the most relevant to recovery and continued
drug abstinence of addicted women. The intent of this study is based on the association of
decision-making and other brain-based behaviors that are pivotal to drug treatment
program success (Fattore, 2015).
Neurochemistry of Cocaine and Methamphetamine
Cocaine is an alkaloid ester and a tropane alkaloid naturally grown and prepared
from the leaves of the coca bush found primarily in Peru, Bolivia, and Columbia
(EMCDA, 2016; Jonkman & Kenny, 2013). The processed impure residue derived from
pure cocaine is known as “crack cocaine” (Pinel, 2011). In its capacity as a central
nervous system (CNS) stimulant, cocaine triggers numerous neurotransmitter systems in
the brain (Koob & Volkow, 2010). Two of these systems are the dopamine and limbic
reward systems, in which cocaine interactions produce interactions between
neurotransmitters leading to some of its most pleasurable and rewarding effects,
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including feelings of euphoria, well-being, self-confidence, alertness and a decreased
desire for food and sleep (Bell et al., 2014; Ballard et al., 2015; Gould, 2010).
One of cocaine’s most important roles in the dopamine system is to prevent the
synaptic reuptake of dopamine (Rothman et al., 2008). Unlike other drugs, cocaine does
not directly stimulate the dopamine system; however, it does permit neural components
of the system to be stimulated by blocking dopamine reuptake transporters’ ability to
evacuate from the intracellular space (Rothman et al., 2008). Studies of cocaine
addiction in women find that cocaine can modify communication pathways between
neurons (synaptic plasticity). Exploring communication associations between neural
systems and the modifications that occur during use is essential in comprehending the
bond of persistence of female cocaine addiction (Garavan et al., 2008; Rothman et al.,
2008; Moeller et al., 2014).
Cocaine abusers tend to go on binges also known as “cocaine sprees” in which
extremely high levels of intake are maintained for a day or two (Goldstein & Volkow,
2011; Pinel, 2011). During the intake period, users become increasingly tolerant of the
euphoria- producing effects of the drug (Nephew & Febo, 2012; NIDA, 2013). Adverse
effects of cocaine sprees include bouts of sleeplessness, tremors, nausea, hyperthermia
and psychotic behavior; however, more severe reactions can result in a loss of
consciousness, heart attack, stroke, or death (Pinel, 2011). Although users can develop a
tolerance of cocaine’s effects (e.g., to the euphoria), repeated exposure to the drug
sensitizes subjects (makes them more responsive) to its motor and convulsive effects
(Potenza et al., 2012).
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Cocaine and MA use during pregnancy is especially risky to the fetus and can
cause complications, including placental abruption, preterm labor and delivery, and
maternal seizures (Bhuvaneswar et al., 2008). Pregnant women might also experience
other serious problems due to insufficient medical or prenatal care mediated by continued
drug use during pregnancy (Malek, 2012).
Methamphetamine (MA) is a derivative of a class of CNS stimulant drugs known
as amphetamine and is usually administered orally in its more potent form called damphetamine (Taylor et al., 2013). Since the 1990s the popularity of d-amphetamines
was surpassed by several of its highly dominant relatives: 3, 4-methylenedioxy
methamphetamine (MDMA or ecstasy), which is consumed orally, and
methamphetamine, or “meth,” typically taken in a smokable, crystalline form known as
“crystal” or “ice” (Pinel, 2011).
Methamphetamine can be produced from a wide variety of materials and methods.
The ability to cheaply and quickly manufacture MA has increased potential for abuse and
financial attraction for both users and manufacturers (NIDA, 2013; Rusyniak, 2013).
Methamphetamine’s psychological effects, like those of cocaine include a heightened
sense of euphoria or well-being, elevated alertness, increased vigor, decreased food
intake and decreased sleep time (Bell et al., 2014; Taylor et al., 2013).
Methamphetamine and cocaine exhibit similar physiological effects in
administration, including a rise in respiratory rate, increases in dilation of the pupils,
elevated heart rate and irreparable damage to small blood vessels in the brain (Pinel,
2011). In addition, critical body system overload such as uncontrolled spikes in
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temperature and seizures are indications of an MA overdose, and if immediate medical
treatment is not administered, death can occur (Pinel, 2011; Rusyniak, 2013). In
prolonged use of MA (as with cocaine), tolerance develops, and in repeated exposure
may produce desensitization requiring more frequent and increased quantities of the drug
(Andersen et al., 2012; Baicy, 2007; Rusyniak, 2013).
The probability for female cocaine and MA abusers to relapse after treatment is
significant in terms of their drug of choice (Fridberg et al., 2013; Volkow et al., 2011a).
Although this study does not aim to analyze the independent contributory effects of
cocaine or MA in cognitive or executive function impairments, some critical distinctions
in terms of their neurologic effects for female users exist (Fridberg et al., 2013; Mahoney
et al., 2010). First, methamphetamine is viewed as an aggressor in the pre-synaptic
discharge of dopamine in the mesolimbic reward system (Pinel, 2011; Yu et al., 2015).
Second, current neuroscience research demonstrates higher neurotoxic effects in animals
and in humans, thereby adding to the risk of addiction and adverse physiological events
(Herbeck & Brecht; 2013; Siegel et al., 2010).
Unlike cocaine, MA does cross neuronal cell membranes and enters the
microscopic sacs (called vesicles) where neurons store dopamine (Yu et al., 2015).
Methamphetamine is believed to damage the storage sacs and the neuron’s axonal
endings, causing dopamine to leak uncontrollably into the synapse (Everitt, 2014).
Methamphetamine can also cause neurotoxicity indirectly by mobilizing dopamine out of
the safe storage vesicles within the neuron and into the neuron’s cytoplasm (the inner
core of matter), where it is changed to noxious and volatile chemicals (Everitt, 2014).
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Once administered, MA is speedily absorbed by plasma and tissue enzymes; however, the
body processes MA more gradually, which frequently results in a prolonged “desirous”
state, despite the probability of dangerous neurotoxic effects (Volkow et al., 2015).
Although the half–life (effective duration of action) of cocaine is 1-2 hours, a single dose
of MA may produce an effect for 8-12 hours (Yu et al., 2015). The abuse of MA can also
carry significant health risks to pregnant women and their unborn children. Pediatric
studies support that MA abuse during pregnancy is associated with increased stress,
lower birthweight and more developmental problems in babies born to MA-abusing
mothers (Pinel, 2011).
Gender and Addiction
National data reports estimate that in 2012, more than 22.2 million people over
the age of 12 were categorized as substance abusers or substance dependent in the United
States (NIDA, 2013). These data also demonstrate the significance of gender in
substance abuse patterns, including drug of choice, onset, and frequency of use (Bobzean
et al., 2014; Du et al., 2013: Greenfield et al., 2010). A report from the National Survey
on Drug Use and Health (CBHSQ, 2015) found that the rate of illegal drug use, including
cocaine and MA, among males was higher (11.5%) than for females (7.3%). A similar
study revealed that females use substances more frequently due to stressful life events
and exhibit higher relapse behaviors than males (Bisagno et al., 2014). Addiction
research suggests that while men are more likely to abuse cocaine and MA, women are
three to four times more likely to become addicted within 24 months of initial use
(Becker, 2012; Kerstetter, 2013; Volkow et al., 2011).
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Although national data show that the overall abuse of cocaine has decreased
slightly for women, annual health studies as recent as 2015 report that the rate of abuse of
methamphetamines has significantly increased (CBHSCQ, 2015). These studies also
indicate the rise in MA use among pregnant women has risen from 8% to over 24% in the
past decade, leading investigators to infer that MA is the most commonly abused drug for
which pregnant women seek help (Greenfield, 2010; NIDA, 2014).
One of the most complex factors in substance abuse research involves multiaddiction or multi-drug use (i.e. alcohol opioids, depressants etc.) that can hinder the
ability to separate the distinguishing effects of cocaine and MA (Covington, 2008; Dean
et al., 2013; Glasner-Edwards & Rawson, 2010; Goldstein & Volkow, 2011; Gould,
2010). Another complication of female cocaine and MA addiction involves multiple
brain pathways that serve to interrupt, modify and severely damage cognition and
executive functions (Everitt, 2014; Thakkar et al., 2014). The increasing use of MA in
the general population is evidenced in part by the following; (a) emergency room visits
have doubled since 2002; (b) admissions to drug abuse treatment programs for general
amphetamine use have grown almost 200% from 1994 to 2004 with a record number of
states (44 out of 45) reporting epidemic increases; (c) criminal activity, imprisonment and
high socio-economic costs have increased, and (d) suicide and accidental death rates
stemming from production, distribution and consumption of MA (DOJ, 2015; NIDA,
2013).
The covert production, generous supply, and increasing abuse of MA during the
1990’s resulted in federal legislation to curb the growing problem of MA demand in the
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United States. The Comprehensive Methamphetamine Control Act of 1996 and the
Methamphetamine and Club Drug Act of 2000 were enacted to specifically address the
need to curb this epidemic (Salo et al., 2010). Gender studies of stimulant drug addiction
explain that prevalence of abuse is only one measure of gender difference, and other
factors that must be considered, from the first experience of cocaine and MA use to the
transition to full addiction. These studies also demonstrate that females are more likely
to start using stimulant drugs (cocaine, MA) at an earlier age, are more likely to escalate
their rate of drug abuse and are more likely to consume greater quantities of drugs than
addicted men (Becker, 2011; Greenfield et al., 2010; Taylor et al., 2013).
Neuropsychology of Addiction and Gender
Neuropsychological studies employ multiple terminologies in defining drug
addiction including the terms “substance use disorder” and “substance abuse” (Gould,
2011). The generally accepted definition of drug addiction is a “chronic, relapsing brain
disease that is characterized by compulsive drug-seeking and use, despite harmful
consequences” (http://www.drugabuse.gov). Addiction researchers define drug addiction
in this manner because addiction can interrupt, reconfigure and modify critical structures
in the brain (Pinel, 2011). Evidence presented in many drug addiction studies indicates
that changes in the brain can have adverse short and long-term consequences that often
result in dangerous and self-destructive behaviors that can subsequently lead to
irreversible physical damage, harm or death (NIDA, 2013; Pinel, 2011).
Executive functions are those brain functions involved in complex cognitions
such as solving novel problems, modifying behavior, considering new information,
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generating strategies, or sequencing complex actions (Eisinger, Larson, Boulware,
Thomas, & Mermelsten, 2018). Executive function tests have also been used to predict
differential rates of attrition of female drug abusers compared with male drug abusers
(Goldstein & Volkow, 2011; Marceau, Kelly, & Solowij, 2018). Executive systems
coordinate, control, and assist in neural processes of goal-orientation in learning and
decision-making (Hart, Marvin, Silver, & Smith, 2012; Potenza et al., 2012).
Psychological studies of addiction indicate that only a small portion of individuals
(less than 20%) who use illicit drugs, including cocaine and MA, will become addicted
(Badiani et al., 2013; Becker et al., 2012). These data suggest that progression from
sporadic to chronic substance abuse depends on several factors, including the gender of
the individual. In their research, Becker et al. (2012) contend that while males have
higher risk factors for MA abuse, cocaine addiction is equally as likely for females as for
males, and in many cases, addiction rates are higher for females (Bell et al., 2014;
Bobzean et al., 2014).
Psychologists have documented more than 70 risk factors for substance use and
dependence including poverty, physical, sexual or emotional abuse or other social
dysfunction that can affect an individual’s decision to initiate the use of cocaine or MA
(DOJ, 2015; NIDA, 2013). Studies of drug dependence reveal that although men report
similar risk factors associated with early use, the decision to continue use is commonly
related to gender.
Women are more likely to report physical and sexual abuse, earlier use of
alcohol, taking drugs with a spouse or partner, or experiencing co-morbidity behaviors
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(for example, chronic depression) as likely reasons to commence or continue drug use
(Becker et al., 2012; Greenfield et al., 2010; Hartwell, Moallem, Courtney, GlasnerEdwards, & Ray, 2016). These explanations provide some insight in terms of initial
drug-taking behaviors; however, they do not fully answer the question of why increasing
numbers of women continue their illicit drug use despite complications that substance
abuse adds to their lives. Furthermore, these rationalizations do not adequately address
why women are more likely to express persistent drug-related cravings or why they are
more likely than men to return to drug abuse even after treatment (Becker et al., 2012).
Neuropsychological studies propose that illicit drugs, including cocaine and MA,
while targeting different molecular structures, carry the same action potential of
escalating dopamine (DA) neurotransmission in the nucleus accumbens (NAcb)
particularly in the mesolimbic system of the brain (Everitt, 2014; Koob & Volkow,
2010). The frequency and predictability of these actions have led to widely held views
that the DA system is directly responsible for reinforcing substance abuse behaviors and
motivating addicted individuals to continue seeking and using drugs in order to avoid the
effects of withdrawal (Everitt, 2014; Mitchell & Potenza, 2015).
A review of the neuropsychological literatures reveals that risk factors for drugseeking, potential addiction and relapse vulnerabilities in females are closely related to
conditioning cues associated with brain behaviors in drug abuse (Greenfield, 2010;
Fattore, 2014). In addition, theories of brain behavior related to cognitive and executive
impairments underscores important sex differences. Although neuroscience studies
suggest that the path to cocaine and MA addiction, while similar for males and females,
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reveals specific differences in neural processes for female addicts (Greenfield et al.,
2010).
Studies of treatment attrition and relapse also substantiate that females
demonstrate greater enhancement of the dopamine systems during initial drug exposure
than do men. This effect on the dopamine system might impact a woman’s ability to
maintain abstinence after treatment (Du et al., 2013; Kennedy et al., 2013; Shrestha et al.,
2015). While there are fewer gender-specific studies related solely to drug addiction,
existing research supports the view that gender differences persist in patterns of
activation in neural systems that undergird pathways to drug addiction (Becker et al.,
2012).
According to Becker et al. (2012) differences in neural pathways are also useful in
understanding how these systems might contribute to higher risk factors of addiction for
women. Evidence from neuroscience research demonstrates that the mesolimbic
dopamine system, comprising the ventral tegumental area (VTA) and nucleus accumbens
(NAc), is the brain’s most important reward pathway (Bell et al., 2014; Rusyniak, 2013).
The VTA and NAc circuit is a primary sensor of rewarding stimuli in humans (Bell et al.,
2014). Under normal operating conditions, the VTA and NAc regulates an individual’s
response to natural rewards, including food, sex, social interactions, and plays a primary
role in motivation and incentives (Goddard et al., 2013). In simpler terms, activation of
the circuit instructs an individual to repeat the action that brought about the reward
(Goddard et al., 2013).
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The mesolimbic system also informs the brain’s memory centers to pay special
attention to all features of the rewarding experience in order that the experience be
repeated in the future (Goddard et al., 2013; Pinel, 2011). The VTA is the site of
dopaminergic neurons, which inform the individual whether an environmental stimulus
(natural reward, drug of abuse, stress) is rewarding or aversive (Bell et al., 2014). The
NAc, also called ventral striatum, is a principal target of VTA dopamine neurons. This
region mediates the rewarding effects of natural rewards and drugs of abuse (Gould,
2010; Volkow et al., 2011b). The amygdala is particularly important for conditioned
forms of learning (Milton & Everitt, 2012). The amygdala helps an individual establish
associations between environmental cues and whether that experience was rewarding or
aversive (Pinel, 2011). The hippocampus is critical for declarative memory, the memory
of persons, places or things. Along with the amygdala, it establishes memories of drug
experiences, which are important mediators of relapse (Pinel, 2011; Rusyniak, 2013).
The limbic reward system (also known as the dopamine or brain reward system)
is thought to be the most significant component in terms of the neurological
reinforcement structure (Rusyniak, 2013). In addition, every known substance of abuse
including, cocaine, methamphetamine, nicotine, alcohol, and heroin in some way
produces an effect on the limbic system (Goddard et al., 2013). These drugs, in turn,
produce changes in the nucleus accumbens by signaling an increase in the
neurotransmitter dopamine, which assists in pleasurable feelings of euphoria and ease
(Pinel, 2011). Dopamine is responsible for assistance in the brain’s ability to control
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movement, executive and cognitive function, motivation and reward processes
(Lucantonio et al., 2012; Pinel, 2011).
Increases in dopamine levels are known to encourage short-term highs in
emotions, moods and motor activity; however, abnormally elevated dopamine amounts
can produce antagonistic effects, including high anxiety, aggressiveness, anger, paranoia,
hallucinations and inappropriate behaviors (Volkow et al., 2011b). The role of dopamine
and its salient effects on the limbic reward system, including its role in reinforcement and
motivation, are considered the common link to drug abuse so much so that dopamine has
been labeled as the “master molecule of addiction” (Hegarty et al., 2013; p. 124).
Terminologies associated with cocaine and MA as well as other drugs encompass
a wide range of psycho-physiological effects that most commonly include changes in
brain behavior, cardiovascular events, mood swings and sleep disturbance (Rothman et
al., 2008). Extensive use and increasingly high dosages of these stimulants often lead to
even more serious events, including psychotic actions or fractured thought patterns. In
tests of chronic duration, laboratory results indicate that the propensity for frequent selfadministration is a result of the highly reinforcing properties of these drugs (Ballard et al.,
2015; Rothman et al., 2008).
Researchers have theorized that the same neural pathways responsible for natural
reinforcers (i.e., food, drink, and sex) potentially provide more than “rewarding” effects
during drug use (Balconi et al., 2015; Gould, 2010; Seigel et al., 2010; Taylor et al.,
2013). In the progression from occasional use to addiction, the desirable effects formed
in neural pathways can become so powerful so quickly that the frequency of use is likely
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to increase, thereby rendering the user helpless to control these events (Pinel, 2011).
Chronic use of cocaine and other stimulant drugs increases modifications in the brain’s
normal neurochemistry including changes in “the y-amniobutryic acid and glutamate
systems and brain circuitry via synaptic plasticity processes” (Rothman et al., 2008, p.
459). Neuropsychological studies conclude that withdrawal from stimulant drugs is
related to deficiencies in DA and 5-HT functioning systems (Everitt, 2014; MorenoLopez et al., 2012; Moeller et al., 2010).
Over a noticeably short period, stimulant drugs are most effective in modifying or
interfering with normal communications between reward circuits and neurons in the brain
(Moeller et al., 2014; Pinel, 2011). When administered, stimulants, including cocaine
and MA, disrupt the dopamine neurotransmitter system. These interruptions occur when
the post synaptic neurons become hyperactive by immediately elevating dopamine levels
in the synaptic area, thus allowing excessive presynaptic releases or preventing the
normal pattern of reuptake of dopamine (Koob et al., 2010). For the drug user, these
extracellular DA levels and reward system dysfunctions typically leads to pleasurable
mood changes (feeling of satisfaction, ease and calmness) and enhanced motor activity.
The psychological effects of cocaine are much shorter in duration than those of
MA, and, for females, this shorter duration becomes problematic when administration
must occur more often to induce the initial feelings of euphoria (Gould, 2010; Everitt,
2014). Neuropsychological studies of addiction in women demonstrate that the
probability of becoming addicted begins with increasing rates of frequency and elevated
tolerance for drug repetition in the mesolimbic reward systems of the brain (Fox et al.,
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2014; Du et al., 2013; Taylor et al., 2013). Generally, the repetition of drug use is
expected if first use is deemed pleasurable (rewarding), which can lead to dependence.
However, more recent studies reveal that even initial drug use can extend well beyond the
mesolimbic reward system (Saunders et al., 2013). The neural consequences of repeated
drug use have the potential for “causing the user to become increasingly sensitive to the
both the drug and drug associated cues, which can result in pathological drug-seeking or
“wanting” (Taylor et al., 2013, p. 30).
Gender, Cognition, and Executive Function
Complicating the cocaine and MA problem for female addicts is verification that,
as a psychostimulant drug, MA provides a neurotoxic affect to dopaminergic frontal areas
of the brain and invokes neural deficits in mechanisms of cognition and selective
attention (Koob & Volkow, 2010). Cognitive deficits demonstrated by MA users have
been linked to neurotoxic events involving numerous neurotransmitter structures located
throughout the cortex (Pinel, 2011; Salo et al., 2009). Harm-inducing events linking MA
abuse to frontal striatal areas of the brain including the stratum, prefrontal cortex, anterior
cingulate cortex and amygdala have led to a wide range of cognitive defects in humans
(Baicy, 2007). Methamphetamine-dependent individuals have also demonstrated
cognitive deficits in relationship to increased performance problems, specifically on tasks
that entail the withholding of extraneous information, decision-making and working
memory (Rusyniak, 2011; Salo et al., 2010).
Everitt (2014) notes that while many of the commonly known drugs including
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cannabis, alcohol, and heroin have a range of different molecular goals, they also have
similar propensities to increase dopamine (DA) transport in the nucleus accumbens
(NAcb) region of the brain. Neuropsychological studies indicated that in addition to
damage to the mesolimbic system which is vital to dopamine and serotonin
neurotransmission, deficits in cognition and executive function are also evident in male
and female addicts (Everitt, 2014).
Neuropsychological studies have determined that chronic cocaine and
methamphetamine abuse pose a significant threat to cognitive and executive functions in
neural processes of humans and animals (Herbeck & Brecht, 2013; Kiluk et al., 2011;
Siegel et al., 2010). Cocaine and MA substance-dependent individuals have
demonstrated deficits in the domain of executive functioning. Executive function
“involves the ability to plan, judge, and weigh several options, to make complex
decisions, to have an accurate perception of one’s own abilities, and to implement,
organize, and control other cognitive functions such as memory” (van der Plas et al.,
2009; p. 706).
A critical issue related to interrupted cognitive and executive function is the
increased likelihood that these impairments will reinforce a cycle of sustained use in the
abuser even in after treatment intervention (Ballard et al., 2015). Among the most
studied characteristics associated with cognitive and executive function are the disruption
of “normal” learning and memory schemas and the development of new learning and
memories precipitated by chronic drug use in males and females (Ballard, 2015).
Neuroscience data add that stimulant drugs such as cocaine and MA not only exhibit
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temporary disruptions but also can modify short and long-term memory by establishing
strong associations between drug cues and drug reward mechanisms (Hartwell et.al,
2016; Herbeck & Brecht, 2013). Once these cues and drug reward mechanisms activate,
these associations are not easily broken, thus rendering the user less control over drug
seeking and use (Winhusen et al., 2013).
Studies comparing the performance of cocaine and MA-addicted males and
females on neuropsychological tests of executive function found that females were
significantly more likely to demonstrate impairments (van der Plas et al., 2009). These
researchers compared the performance of alcohol-dependent individuals, cocainedependent individuals, and MA dependent individuals with healthy controls (matched by
sex) on various measures of complicated decision-making tests using the Iowa Gambling
Task, functional memory (Tic Tac Toe), cognitive elasticity (the Wisconsin Card Sorting
Task), and response inhibition (the Stop Signal-RT). Results revealed that cocaine and
MA-addicted males and females were impaired in every category of memory and
decision-making, except for response inhibition. In addition, cocaine and MA-dependent
women exhibited significantly more impairment than men who were addicted. Taken
together, these findings suggest that gender and drug of choice have differing effects on
executive functions (van der Plas et al., 2009).
The Iowa Gambling Task (IGT) is an experimental decision-making test that
requires the integration of different aspects of executive functioning for successful
completion (Barry & Petry, 2008). The IGT is used frequently in cognition and executive
function research as a means of measuring how well a participant can utilize complex
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decision-making skills that require clarity, quick thinking and the ability to delay
gratification when presented with various rewards (Verdejo-Garcia et al., 2007). One of
the most prominent aspects of the IGT is the requirement that participants give up
immediate rewards (“play” money) for delayed profit. In similar studies of addiction and
executive impairment, females were more likely than males to make decisions to select
temporary rewards over the long-term rewards even at the risk of losing all profits (van
der Plas et al., 2009; Morie et al., 2014).
The consistency with which female cocaine and MA addicts were found to have
poorer performance on various tests of executive function than men has brought about
new questions regarding reward and punishment mechanisms, and whether these reward
systems in the brain operate differently for female addicts when compared with male
addicts. Adinoff et al. (2010) maintained that neuroimaging tests reveal differences in
how reward and punishment mechanisms differ by sex. An important brain region
involved in processing many types of reward and punishment in response to
environmental changes is the orbitofrontal cortex (OFC), the ventral and medial
prefrontal cortex (VMPFC) (Moreno et al., 2012; Shrestha et al., 2015).
Van der Plas et al. (2009) addressed the role that gender differences play in
substance use disorders. These researchers found that cocaine and MA-addicted women
exhibited serious impairments in decision-making abilities compared with cocaine and
MA-addicted men in terms of PFC functioning. Other neuropsychological studies
reaffirm that differences in brain activation patterns by sex could be related to reward
versus punishment, thus reinforcing problems associated with a woman’s decision-
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making ability to discontinue drug use (Volkow et al., 2011). Van der Plas et al. (2009)
further suggests that biological vulnerabilities in OFC systems could further explain the
“telescoping” syndrome, a set of symptoms that includes the progression to drug
dependence in which females are believed to progress more quickly to drug dependence
even after a late onset of substance use.
As evidenced in their study, Adinoff et al. (2010) revealed that addicted
individuals were significantly more likely to show reduced activity in the OFC when
performing on the Iowa Gambling Task when compared with nonaddicted subjects. In
addition, women demonstrated greater memory deficits than addicted men in terms of
decision-making and working memory. Addiction studies suggest that working memory
is impaired in both males and females; however, females experienced significantly
greater dysfunction in this area of the brain (Adinoff et al., 2010).
Drug abuse studies related to gender propose that deficits in the working memory
domain are not simply a matter of memory organization or categorization, rather
impairments may be due to executive control problems (Ide et al., 2014). Specifically,
van der Plas et al. (2009) found that individuals addicted to alcohol, cocaine, or
methamphetamine performed below normal levels on the working-memory task, but
found that increasing the memory load did not influence performance. Although stress
and drug-cue exposure increase drug cravings and contribute to relapse in cocaine
dependence, no previous research has directly examined the neural correlates of stress
and drug-induced cravings in cocaine-dependent women and men relative to comparison
subjects (Streeter et al., 2008).
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Fridberg et al. (2013) administered a neuropsychological test of decision-making
(the Iowa Gambling Task) for males and females with substance dependence and a
history of childhood conduct disorder (HCCD) compared with healthy controls to assess
working memory load. A primary function of working memory is to mediate the ability
to sustain or suppress information and to resist distraction. Lower working load memory
is associated with increases in impulsive decision-making in healthy adults. Substancedependent males with HCCD made fewer advantageous decisions than IGT control men.
Working memory capacity was reduced more significantly for substance-dependent
women with HCCD than in substance-dependent men with HCCD (Fridberg et al., 2013).
Worhunsky et al. (2013) administered a Stroop Word Color Task (SWCT) as part
of an exploratory study to examine systems of functional connectivity supporting
cognitive control among cocaine-addicted subjects. Independent Component Analysis
(ICA) was utilized in fMRI data to assess whether regional activations supporting
cognitive control activities operate in functional systems in terms of performance and
treatment outcome in cocaine-dependent participants. The study compared the
performance of participants on a SWCT task during fMRI before entering treatment and
compared these subjects to a control group. Cocaine-addicted males and females
demonstrated differences in three out of five networks: (a) reduced involvement of a
fronto-cingular network contributing to conflict management in treatment retention, and
(b) increased engagement of two bottom-up subcortical, (c) and ventral prefrontal
networks linked to cue-elicited motivation correlated with abstinence during treatment
(Worhunsky et al., 2013).
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Summary
The review of literature evaluating cognitive and executive function in cocaine
and methamphetamine use supports the existence of gender differences in onset,
maintenance and treatment outcomes (Anker & Carroll, 2011; Bobzean et al., 2014;
Fattore et al., 2014). National health data offered statistical information on current use
and addiction rates among women in the United States with an emphasis on the
detrimental personal and societal costs of this ongoing problem (NIDA, 2017). Cocainedependent women often experience heightened vulnerabilities to social, physical and
psychological consequences of substance use, which can encourage a return to use if
strong social supports are not available (Winhusen et al., 2013a).
In both classical and operant conditioning theories, sex differences have been
demonstrated in various areas of human learning (Shors, 2016). Classical and operant
theories of drug abuse support that women are more likely respond to the desirable
effects of cocaine and MA in the reward systems of the brain and to avoid withdrawal,
thereby increasing their likelihood to continue their cycle of abuse (Goddard et al., 2013).
Tests performed by researchers in the field of neuropsychology designed to measure
cognitive and executive function revealed that cocaine and MA-addicted women were
significantly impaired in key regions of the OFC in the brain (the region that controls
complex decision-making and error processing) (Everitt, 2014; Saddoris et al., 2011).
These problems signal that neural processes in terms of learning and memory affect
addicted women differently than addicted men, in heightening vulnerability to relapse
and life-threatening outcomes (van der Plas, 2013).
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Studies of the literature covered in this chapter contend that the experiences of
addicted females are not well-documented. Among the major reasons provided for the
lack of empirical studies and female drug addiction are as follows: (a) women are not
included as often in neuropsychological studies of drug addiction; (b) issues unique to
women are not widely addressed in these studies; and (c) treatment planning often locates
the addiction of women in relation to those of male addicts, thus ignoring specialized and
relevant treatment to improve outcomes. The studies presented in this chapter attempt to
address some of these neglected aspects, particularly the onset, maintenance, withdrawal
and relapse women undergo during the addiction cycle. The empirical research offered in
this literature review provides valuable information regarding gender differences across a
spectrum of neuropsychological issues, including a propensity to develop and sustain
cocaine and MA addictions, and the problems that may manifest in cognitive and
executive functioning negatively impacting treatment and encouraging relapse.
While prior research on gender differences consistently failed to fully include the
participation of female cocaine and MA addicts, current research does not go far enough
in investigating neural situations unique to women’s addiction experiences, or in pursuing
efforts required to curb the rise in abuse, or in conducting extensive research in treatment
assessments evaluation (Becker et al., 2017; van der Plas, 2011). While Cocaine and MA
addiction researchers are offering greater insight into female addiction, present disparities
in examining neurocognitive processes in female addiction emphasizes an intentional and
prominent gap in current addiction literature.
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Chapter 3: Research Method
In my research I examined an individual’s extent of participation and performance
on a test of neurocognitive function in a substance abuse treatment program for cocaine
and MA-addicted adult males and females. This chapter includes a description of the
study design and rationale, research setting, sample and sampling procedures, data
collection and analysis, instrumentation and study materials, validity and threats to
validity, and ethical protocols and procedures relevant to this research. The research
questions and hypotheses guide data analysis procedures for this study. This present
study utilized data released by the National Institute on Drug Abuse and made available
for public use via the Clinical Trials Network (NIDA, 2013). The primary data for this
present study were extracted from (CTN-0031A), an archival study derived from the
parent study (CTN-0031), a randomized controlled trial from multiple sites (NIDA,
2013).
Research Design and Rationale
A quantitative, correlational method was employed as the research design for this
study. I examined the extent of a person’s participation in an eight-week substance
abuse treatment program for adults addicted to cocaine and MA. In this study, four
independent variables were analyzed: (a) participants’ performance on the ComalliKaplan version of SWCT, (b) participants’ gender, (c) participants’ age, and (d)
participants’ race/ethnicity. There were two dependent variables: (a) the total number of
hours of treatment received during the eight-week period, and (b) the differential between
the number of hours of treatment received during the first four weeks and the number of
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hours of treatment received during the last four weeks. The second measure was
included to address the issue of participant attrition. This study did not appear to present
any problems in terms of time or resource constraints. In this study, multiple regression
and a series of bivariate analyses were used to examine the relationship: (a) between the
independent variables and the total number of hours of treatment received during the
eight-week period, and (b) between the independent variables and the differential
between the number of hours of treatment received during the first four weeks and the
number of hours of treatment received during the last four weeks.
Correlational methods in quantitative research examine whether a relationship
exists between two or more variables, although correlation does not indicate causation
between variables (Creswell, 2009). A correlational design was appropriate for this
research in that neuropsychological studies have demonstrated relationships between
performance on tests of neurocognitive function and the gender of participants enrolled in
drug abuse treatment programs (Ballard et al., 2015; Bingham & Fry, 2010; LoBue et al.,
2014; Scarpina & Tagini, 2017). In addition, a correlational method allows for types of
testing that are otherwise impractical for human subjects who are active abusers of illicit
drugs. Although studies of executive function and gender typically underscore patterns
of neurocognitive interference unique to gender, not all associations between these
variables demonstrate such distinctions (DeVito et al., 2012).
Correlational design studies related to neurocognitive function and extent of
treatment participation for cocaine and MA-addicted males and females are not ample in
neuropsychological literature. Contemporary psychological research contends that an
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insufficient number of gender-based studies in substance abuse addiction has hindered
critical aspects of evaluation and treatment, particularly for females (Crane et al., 2013;
LoBue et al., 2014). More recent research has explored neurocognitive processes by
specifically comparing drug treatment experiences of females and males (Becker et al.,
2017; LoBue et al., 2014). In their research, Becker et al. (2017) found that when
compared with men, women had higher attrition and poorer treatment outcomes, thereby
prompting greater recovery obstacles. These factors are attributed in part to the greater
severity of social and psychological issues women present upon entering treatment
programs, including deficits in neurocognitive functioning (i.e., poor decision-making,
greater impulse control and inconstant working memory).
According to Creswell (2009), quantitative research is a “means for testing
objective theories by examining relationships among variables” (p. 4). A quantitative
research design is appropriate for this present study because it attempts to investigate
relationships among variables not previously addressed in the original data. In addition,
findings from a quantitative research design are likely to support generalizability to a
larger population because of the larger sample available from the original study (Choy,
2014). Qualitative research designs were not deemed appropriate for this study because it
is not possible to explore the real-life experiences of participants from the CTN-0031A
study.
Multivariate regression is used frequently in studies of neurocognitive function
and extent of drug treatment program participation among cocaine and MA-addicted
individuals. In previous research studies, Shrestha, Huedo-Media, and Copenhaven
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(2015) employed multiple regression analysis to explore the relationship between selfreported neurocognitive impairment among high-risk male and female cocaine abusers
enrolled in a methadone treatment program. A similar study by Fernandez-Montalvo et
al. (2017) used multiple regression analysis to examine gender differences in treatment
attrition between addicted males and females enrolled in an outpatient drug treatment
program. Fridberg et al. (2013) studied gender differences among MA-dependent males
and females enrolled in substance abuse treatment programs, using four domains: drug
use history, psychological burden, current symptoms, and coping strategy. Employing
multiple regression analysis, Fridberg et al. (2013) found that although men reported
earlier abuse of alcohol and drugs than women, women reported greater severity of use of
MA, more psychological burdens, and poorer coping strategies than substance-abusing
men.
Methodology
Population, Sampling and Sampling Procedures, Study Inclusion and Exclusion
The population for this present study were active cocaine and MA-addicted men
and women of at least 18 years of age who met all requirements as participants from the
CTN-0031A study (NIDA, 2013). In my study, participants were a randomly selected
sample of 186 men and women who (a) participated in drug treatment programs from six
sites; and (b) completed the Comalli-Kaplan version of the SWCT. Random selection
ensured that each potential participant had an equal probability of being selected, thus
confirming that study participants are representative of the target population (Creswell,
2009). NIDA drew the sample and provided the participant-specific data. According to
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calculations based on G*Power Version 3.1.9.2, the sample of 186 made available for the
present study would yield a power level of 0.99 for an effect size of 0.30, meaning that
there is a high probability of finding a significant effect if one exists.
Participants. Participants randomly selected from the CTN-0031A study and
deemed eligible for this present study were required to meet the following criteria: (a) be
at least 18 years of age at the time of selection for the CTN-0031 study, (b) meet the
DSM-V criteria of abuse or dependence on MA and/or cocaine, (c) must declare the use
of cocaine and/or MA as the primary drug(s) of choice, (d) be able to understand the
relevant content of the study, (e) be able to provide written informed consent in English,
(f) be able to sign all appropriate documentation for study access, and (g) be able to fully
distinguish the colored stimuli on the Comalli-Kaplan version of the SWCT. In this
present study exclusion criteria followed the protocol of the CTN-0031A studies in that
research participants were excluded from the study if they had previously experienced
strokes or certain seizure disorders.
Materials and procedures for recruitment, consent participation, and data
collection. Efforts to enlist participation into the CTN-0031A study specified those
individuals who met the DSM-V conditions for current abuse or addiction of cocaine and
are approved as their chief drug of choice during intake screening (American Psychiatric
Association, 2013). Potential study participants were provided with information about
the treatment study and given an opportunity to review, inquire about, and to sign the
informed consent document. Any individual presenting problems in understanding the
study requirements in the consent form were asked to review this information with the
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study staff to ensure that potential participants fully comprehend the study requirements.
If a participant exhibited continued difficulties in comprehending informed consent, that
participant was exempted from study participation.
Participants who were willing to join the CTN-0031A study, yet demonstrated
problems in grasping the scope of the study intent or informed consent material, were
asked to review any sections that were misunderstood and discuss those sections with a
research staff member until the candidate exhibited complete comprehension of the
information and could willingly provide full and signed consent for participation. If
considered eligible for the CTN-0031A study, each participant would attend a single
research visit that took approximately 1½ hours to complete.
Participant Reimbursement: Participants received compensation related to
expense incurred for their transportation, time and inconvenience. Compensations was
provided via cash, vouchers or retail scrip at the direction of each study site. A monetary
recommendation was set at $50 for those participants completing the entire research visit
and $10 for those who did not complete the study or were deemed ineligible. Participant
reimbursement would vary across study sites in accordance with study sites and local
IRB guidelines (NIDA, 2013).
After a study participant signed the consent form. Participants also completed
minimal screening to determine a possible history of stroke and/or seizure disorder, and
whether the participant could correctly distinguish the colored stimuli on the SWCT.
Based upon this eligibility, participants then completed the research visit, which takes
approximately 128 minutes. Visits were expected to occur during the first week of a
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participant’s acceptance and randomization into the study; however, they could also take
place during the second week. In the CTN-0031A study, each participant’s treatment
attendance, including all information related to the actual dates, number of hours of
attendance (for group and individual treatment sessions) over an eight-week period was
to be documented by clinic staff (NIDA, 2013).
The NIDA data-share website is an electronic environment that permits data from
published clinical trials to be disseminated to scientific researchers and the public for
purposes of enhancing understanding, promoting new research and supporting further
analysis (NIDA, 2013). The protection of human subjects is paramount for NIDA; data
on this site have been completely de-identified to prevent any links to actual research
participants. De-identification includes the removal of all Personal Health Information
(PHI) and other identifiers that are not contained in PHI but could potentially lead to
“deductive disclosure,” including comment fields and site participation numbers. Deidentifiers specific to the study were documented in the research protocols (NIDA, 2013).
Permission to use CTN-0031A data was obtained from NIDA’s Clinical Trials
Network (CTN) website by completing the NIDA Data Share and Registration
Agreement and by meeting use and responsibility requirements for dataset use.
Permission to use the shared datasets is available on the NIDA website
(https://www.drugabuse.gov). Shared data files are found at the NIDA clinical trial
network site and are available for download in two formats: SAS (transport files and
ASCII (CSV).
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As part of the NIDA Registration Agreement, the user also agrees (a) not to
manipulate any information to establish identities of any of the subjects from whom study
material was obtained; (b) to retain control over the received data and not to transfer any
portion of the received data with or without charge to any other entity; (c) to notify the
user’s Institutional Review Board (IRB) operating under guidelines approved by the
Office of Human Research Protections (OHRP) as required by the recipient’s affiliated
university, and in accordance with the Department of Health and Human Service
regulations for any new research projects based on the NIDA data; (d) to acknowledge
the NIDA database and the specific trials accessed in all oral and written presentations
and publications resulting from analyses of the received data; (e) to maintain security and
privacy of the received data for as long as necessary per local and federal requirements;
and (f) that NIDA or its affiliates may contact the recipient concerning publications of
other issues regarding the use of the data (NIDA, 2013).
Instrumentation and Operationalization
Data items specific to participants’ gender, age and race/ethnicity was extracted
from the general demographic questionnaire section of CTN-0031A. The race/ethnicity
categories were White non-Hispanic, Black/African American, Hispanic/Latino, Asian,
Native Hawaiian/Pacific Islander, Native American/Alaskan Native, and Other. Any
specific identifiers, including name, location, incarcerations and other personal identifiers
of study participants were eliminated from the CTN-0031A dataset files.
Participants’ gender, age and race/ethnicity constitute three of the four
independent variables to be used in this study. The fourth independent variable is the
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participants’ derived interference reaction time (RT) on the Comalli-Kaplan version of
the Stroop Word Color Task (SWCT), expressed in seconds. NIDA calculated the
summary RT score by subtracting the seconds required to complete Stroop Task 1 from
the seconds required to complete Stroop Task 3. For example, if a participant took 49
seconds to complete Task 1 and 89 seconds to complete Task 3, the RT score would be
40. The lower the RT score for a participant, the better.
Test of executive function: Stroop Word Color Task. The SWCT is one of the
most reliable and widely used neuropsychological tests of neurocognitive functions
involving selective attention, cognitive control and flexibility, goal-oriented behavior,
impulsivity, and response inhibition processes (Kiyonaga & Enger, 2014; Hurtado et al.,
2014; Streeter et al., 2008). The SWCT is considered an ideal instrument to screen
individuals who may be at risk for lower drug treatment participation and who may be
vulnerable for treatment dropout due to their hypothesized inability inhibit or control
impulsive behaviors that prevent successful drug use avoidance. The staff supervising
the eight-week treatment program recorded daily the number of hours of treatment
received by each participant in the study. The recorded number of treatment hours were
used in measuring the two dependent variables in the study: (a) the total number of hours
of treatment that a participant received over an eight-week period and (b) the differential
between the number of hours of treatment received during the first four weeks and the
number of hours of treatment received during the last four weeks.
The SWCT was originally developed in 1935 by psychologist John Ridley Stroop
to measure selective attention and cognitive flexibility (MacLeod, 2015). The original
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Stroop task has been modified and translated into multiple languages, including Chinese,
German and Japanese (Homack & Riccio, 2004). While there is no one standard version
of the SWCT, there are several editions that are commonly used in neuropsychological
research: the Comalli-Kaplan version (1962), Max Trenerry’s version (1962), Charles
Golden’s version (1978), and the Victoria version (1981).
The Comalli-Kaplan version of the SWCT, developed in 1962, consists of three
sub-sections designed to assess a subject’s ability to suppress interfering stimuli. These
tasks are contained on three stimulus card sets, each containing 100 stimuli (Strauss et al.,
2005). This version is appropriate for this present study because modifications of this
task require that the color-naming card be presented first, that errors be recorded, and that
allowances be made for self-correction of errors before moving on the next stimuli
(Strauss et al. 2005; Winhusen 2013). These modifications serve two purposes in
neurocognitive function and drug addiction studies: (a) individuals who are color-blind
will be quickly identified and, (b) this test procedure maximizes the interference effect by
presenting the word condition just prior to the interference task (Strauss et al., 2005).
The order of the test administration is as follows: color-naming, word-reading and
interference. Three scores, including an interference score, are generated using the
number of items completed on each page, with higher scores reflecting better
performance and less interference on reading ability. Testing for all three SWCT sections
has a completion time of five minutes.
Previous neuropsychological studies have provided strong validity and test
reliability for the SWCT (Shrestha et al., 2015, Strauss et al., 2005). Test-retest
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investigations of the Comalli-Kaplan version indicate that color-naming times are
exceptionally reliable (Strauss et al., 2005). Pilli, Naidu, Pingali, Shobha and Reddy
(2013) demonstrated in normal, healthy populations that the SCWT appears to be
extremely sensitive to the drug effects in terms of complex cognitive skills, including
speed of information-processing, long-term memory, and selective memory, all of which
are required for maximum performance on SWCT.
Sufficiency of instrumentation. In addition to documented validity and test
reliability of the SWCT, this test has demonstrated a relationship between performance
on the SWCT (interference) and executive function in cocaine and MA-addicted
individuals. Research has found that performance on the SWCT is a predictor of
treatment attrition among cocaine and MA drug abusers (Green, Locker, Boyer, & Sturz,
2016; Hagen et al., 2016; Scarpina &Tangini, 2017).
In this present study, it was expected that participants would exhibit greater
cognitive interference in RT performance of executive function comparable to similar
studies that utilized SWCT instrumentation of neurocognition impairments in male and
female cocaine and MA substance abusers (DeVito et al., 2014; King, Alicata, Cloak, &
Chang, 2010; LoBue et al., 2014; Mitchell et al., 2013). It should be noted that while the
CTN-0031A study administered and assessed six neuropsychological tests, in my study,
only the SWCT was evaluated.
The occurrence of decreased color-naming has become known as the “color-word
interference effect” (Winhusen, 2013). There are three components in this task, with
participants using a computerized version of the Comalli-Kaplan SWCT. Pilli et al.
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(2013) noted that the initial task starts when the participant is asked to name a series of
color words (Word task). This component is believed to reflect basic reading rate and
may be affected by cognitive or learning disabilities. Second, the individual is asked to
name the color of a bar (Color task) of X’s (e.g. XXX in blue or green ink). As with the
Word task, performance might be affected by speech motor function or other
neurocognitive function deficits. The final task is the Color-word task on which the
individual is shown the names of colors (e.g., the word “blue” in red ink) and is asked to
name the color of ink rather than the word (Pilli et al., 2013). The subject’s task is to
correctly move from one section to another naming words or naming the ink colors as
quickly as possible with a given time limit of 45 seconds. Scores obtained from each of
the Stroop tasks are derived from interference-reaction time (RT), which is the actual
time allotted for a participant to provide a response.
Reaction time of participants is critical for these tasks in that slower response
times are hypothesized as indicators of neurocognitive function impairments. Wrong
answers, including responses not given in the allotted time, are coded as incorrect
responses. Participants are asked to provide responses to the number of words (Word
task), number of bar colors (Color) and, the number of color words (Color-Word).
Color-word components of the Stroop are used to establish a baseline for
comparison with the Color-Word task. Interference scores involve taking the difference
between the Color task and Color-Word task to measure interference effects. Completion
time for the three tests combined is five minutes (Kiyonaga, & Egner, 2014; Pilli et al.,
2013).
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Data Analysis Plan
The collected data were entered into an SPSS statistical software file, and the
SPSS software was used to perform the analyses for this study. The data file contained
186 cases, each case representing a participant in the study. For each participant, the file
included the demographic variables of gender, age and race/ethnicity, the participant’s
SWCT score, and the number of hours of treatment that the participant received on each
of the 56 days (seven treatment days per week) comprising the treatment program.
SPSS was used to provide the following: (a) descriptive statistics summarizing the
demographic characteristics of the 186 participants in the study; (b) descriptive statistics
showing how SWCT scores vary according to demographic characteristics; (c)
descriptive statistics showing how the level of participation in the treatment program
varies according to demographic characteristics; and (d) inferential statistics addressing
whether patterns observed in this sample can be generalized to a population. For each
participant, SPSS was used to calculate the number of treatment hours for each of the
eight weeks of the program. Then the resulting eight numbers were added together to
obtain the total number of treatment hours for the eight-week program. This new total
number was used as the dependent variable in a regression analysis addressing the first
four research questions in this study.
In addition, SPSS was used to calculate the number of hours of treatment received
during the first four weeks and the number of hours of treatment received during the last
four weeks for each participant. The next step involved calculating the differential
between the number of hours of treatment received during the first four weeks and the
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number of hours of treatment received during the last four weeks. For example, if a
person received 20 hours of treatment during the first four weeks and 10 hours during the
last four weeks, that person’s differential would be -10. That differential number would
be used as the dependent variable in a regression analysis addressing the final four
research questions.
Research Questions and Hypotheses
This study addressed the following research questions and hypotheses, using a
randomly selected sample of 186 addicted individuals:
Research Question 1: Does the Stroop Word Color Task (SWCT) predict the level
of participation when controlling for all other variables?
H01: The SWCT does not significantly predict the level of participation when
controlling for all other variables.
Ha1: The SWCT significantly predicts the level of participation when controlling
for all other variables.
Research Question 2: Does gender predict the level of participation when
controlling for all other variables?
H02: Gender does not significantly predict the level of participation when
controlling for all other variables.
Ha2: Gender significantly predicts the level of participation when controlling for
all other variables.
Research Question 3: Does age predict the level of participation when controlling
for all other variables?
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H03: Age does not significantly predict the level of participation when controlling
for all other variables.
Ha3: Age significantly predicts the level of participation when controlling for all
other variables.
Research Question 4: Does race/ethnicity predict the level of participation when
controlling for all other variables?
H04: Race/ethnicity does not significantly predict the level of participation when
controlling for all other variables.
Ha4: Race/ethnicity significantly predicts the level of participation when
controlling for all other variables.
Research Question 5: Does the SWCT predict the level of attrition in participation
when controlling for all other variables?
H05: The SWCT does not significantly predict the level of attrition in
participation when controlling for all other variables.
Ha5: The SWCT significantly predicts the level of attrition in participation when
controlling for all other variables.
Research Question 6: Does gender predict the level of attrition in participation
when controlling for all other variables?
H06: Gender does not significantly predict the level of attrition in participation
when controlling for all other variables.
Ha6: Gender significantly predicts the level of attrition in participation when
controlling for all other variables
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Research Question 7: Does age predict the level of attrition in participation when
controlling for all other variables?
H07: Age does not significantly predict the level of attrition in participation when
controlling for all other variables.
Ha7: Age significantly predicts the level of attrition in participation when
controlling for all other variables
Research Question 8: Does race/ethnicity predict the level of attrition in
participation when controlling for all other variables?
H08: Race/ethnicity does not significantly predict the level of attrition in
participation when controlling for all other variables.
Ha8: Race/ethnicity significantly predicts the level of attrition in participation
when controlling for all other variables.
This present study used a correlational research design to examine the following:
(a) the relationship between participants’ demographic characteristics and their level of
participation in a treatment program; (b) the relationship between participants’ SWCT
score and their level of participation in a treatment program; (c) the relationship between
participants’ demographic characteristics and their level of attrition in a treatment
program; and (d) the relationship between participants’ SWCT score and their level of
attrition in a treatment program.
The hypotheses were tested through multiple regression analysis, with the
researcher using an alpha level of .05 and a confidence level of 95% to determine
statistical significance. With multiple regression, the researcher can estimate the extent to
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which the values of independent variables predict the value of a dependent variable.
Consequently, in the present study, multiple regression assisted the research in
determining whether treatment participation was associated with SWCT performance,
gender, age and race/ethnicity.
Threats to Validity
External Validity
Validity issues, including test reliability, are present to some extent in all
psychometric tests (Gregory, 2011). Possible threats to external validity (the extent to
which conclusions from a research study can be generalized) have been minimized by
random sampling. In addition, there are other issues specific to external validity because;
(a) the participants in this study represent a unique population (active cocaine and
methamphetamine abusers), (b) polysubstance abuse (use of other drugs) will not be
verified, and (c) individual differences in terms of testing cannot be controlled. Threats
to internal validity in this research are as follows: (a) the ability to control for differences
in individuals, including age, education or reading levels; (b) accuracy in reporting
current use of drugs and unreported drug use; (c) environmental factors associated with
living conditions; (d) emotional stress or physical traumas; (e) legal or impending
incarceration issues; and (f) pregnancy or other recent medical diagnosis.
Internal Validity
Internal validity threats primarily include issues associated with treatments,
procedures or participant experiences that can hinder or threaten the ability to draw
correct conclusions about a research population (Creswell, 2009). Specific types of
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possible internal validity problems associated with this present study include but are not
limited to “selection” and “mortality.” The fact that eligible study participants must be
active abusers of cocaine and/or MA, makes it more difficult predict categorical actions
or behaviors during the treatment process (a sudden illness, actions that threaten
themselves others, non-compliance with treatment protocol), thus presenting challenges
in drawing accurate conclusions about treatment related outcomes. Although it was
expected that some participants might drop out of the drug treatment study (mortality),
there was no way to predict how many or at what point in the treatment phase this would
occur. If a significant number of participants failed to complete the study, drawing
accurate inferences about the population of this research might be more difficult. In
addition to issues of “history” and “maturation” are problems inherent in self-report and
social desirability bias in drug addiction studies.
While self-reporting is a common approach in gathering data in scientific
research, there are several problems that can arise in this reporting method. However,
when utilized properly these data can provide useful in obtaining information related to a
subject’s views, opinions and perspectives regarding a research topic (Althubaiti, 2016).
There are several aspects that accompany self-reported data that should be considered
when designing the self-reporting instrument (Pannucci, & Wilkins, 2010)
Self-reporting data can be affected by an external bias caused by social
desirability or approval, especially in cases where anonymity and confidentiality cannot
be guaranteed at the time of data collection. For instance, when detailing drug usage
among a sample of individuals, the results could underestimate the exact drug use,
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including types of drugs, amounts, frequency of use and other relevant factors. In the
archival study, subjects were asked to respond to a series of questions that included these
specifics (types, amounts, times, etc.) as well as any poly-drug use, including alcohol,
prescription and other forms of illicit drugs. Even when attempting to avoid bias in this
research, it might be necessary to account for any simultaneous effects of other factors
that could bear at least some responsibility for successful participation in the 8-week drug
treatment program study. To better control for reporting common psychiatric illnesses
including depression, the archival study administered the Patient Health Questionnaire to
assist in screening and diagnosis of anxiety, alcohol and eating disorders. In addition, the
Wender Utah Rating Scale was used to screen for ADHD in participants. A structured
interview designed to assess whether a participant had experienced traumatic brain injury
was employed as was participant HIV status using four questions self-reported via the
Multicenter Aids Cohort Study (NIDA, 2013).
Statistical Conclusion Validity
According to Garcia-Perez (2012), statistical conclusion validity is related to the
extent by which data from a research study can be “reasonably regarded as revealing a
link (or lack thereof) between independent and dependent variables as far as statistical
issues are concerned” (Garcia-Perez, 2012, p. 1). In the case of this research, it is
important to be aware of issues that arise in presenting inadequate statistical power,
sample size, effect size, alpha level or violation of statistical assumptions.
Test-retest investigations of the card version indicate that color-naming times are
exceptionally reliable (Strauss et al., 2005). Garcia-Perez (2012) cautions that the
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assumption of validity can be assessed in predictor variables by correlational methods
investigating bivariate relationships. This assumption also holds true in the case of
psychometric functions describing the form of the relationship between physical
magnitude and the performance in a detection, discrimination, or identification task.
Ethical Considerations
Permission for this researcher to use the shared datasets is available on the NIDA
website (https://www.drugabuse.gov/). Shared data files are found at the NIDA clinical
trial network site and are available for download in two formats: SAS (transport files or
sas7bdat) and ASCII (CSV). Completion of the NIDA Registration and Data Share
Agreement are required for accessing data for this present study. The CTN-0031 and
CTN-0031A studies met protocol and regulatory standards as recommended by the
American Psychological Association.
One of the most pressing ethical issues associated with substance abuse research
lies in the fact that unauthorized use of cocaine and methamphetamine in the United
States is illegal and fully punishable by law; therefore, those who conduct research in this
area must be fully cognizant and compliant with legal and ethical protocols in working
with active substance abusers (DOJ, 2013; NIDA, 2017). Ethical issues involving the use
of secondary data and the protection and confidentiality of study participants takes on
greater urgency as access to new technologies becomes more readily available (Bersoff,
2008; Tripathy, 2013).
Confidentiality of data. In the archival study, the following information
regarding participant confidentiality and anonymity was provided: (a) all Case Report
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Forms (CRF’s) were identified only by a coded participant number, (b) all study
information was maintained in confidence with complete divulgence to the IRB, Ethical
Review Committee, or similar expert committee, affiliated institution, and employees
under appropriate understanding of confidentiality with such board or committee,
affiliated institution and employees, and (c) NIDA administrators clarified that no
participant study information would be available for release without written permission,
except as required for monitoring (NIDA, 2015).
In the archival study, data were anonymously collected. Protections for the data
storage and public usage were provided as follows: (a) secondary data were transmitted
to a central depository as requested by NIDA, (b) the database was checked and “locked”
by the Central Data Management to prevent further modification, (c) the data was
archived and stored by NIDA, and (d) the dataset was made available for public data
sharing under NIDA rules and regulations. In addition, this investigator agreed to abide
by all confidentiality protocols associated with the Clinical Trials and data share network
sponsored by NIDA. The investigator reported no conflicts of interest (NIDA, 2013).
Summary
This chapter described a plan for a research study that examines how a person’s
level of neurocognitive function and a person’s gender, age and race/ethnicity seem to
affect the extent of a person’s participation in a substance abuse treatment program for
cocaine and methamphetamine-addicted adults. A total of 186 cocaine and MA-addicted
adults participated in the study. Eight hypotheses were tested.
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Four of the hypotheses addressed the relationship between four independent
variables and the total number of hours of treatment received during an eight-week
period. The other four hypotheses addressed the relationship between the same four
independent variables and the differential between the number of hours of treatment
received during the first four weeks and the number of hours of treatment received during
the last four weeks. The four independent variables are participants’ performance on the
Comalli-Kaplan version of the SWCT, participants’ gender, participants’ age, and
participants’ race/ethnicity. Multiple regression analysis and a series of bivariate
analyses were used to test the hypotheses.
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Chapter 4: Results
Cocaine and MA addiction in the United States is well documented, yet the onset,
maintenance, and treatment outcomes of drug addiction specifically for adult females is
less well known. An individual’s level of participation and rate of program completion
are two of the most significant factors in successful drug treatment recovery and post
program success. This quantitative, correlational study was designed to examine whether
the level of attendance and level of attrition of cocaine and MA-addicted participants in a
substance abuse treatment program is associated with participants’ demographic
characteristics. In addition, this study explored whether a participant’s level of
attendance and attrition is related to the participant’s performance on a test of
neurocognitive executive function.
In my research, I examined secondary data from an archival drug treatment study
(CTN-0031A) provided by the National Institute on Drug Abuse (NIDA, 2015).
Researchers in the archival drug treatment study collected and analyzed data from six
community drug treatment sites across the United States that included (a) the
participants’ gender, age and race/ethnicity; (b) the participants’ performance on the
SWCT test and (c) the participants’ level of participation in the treatment program.
I obtained IRB approval (#03-26-19-0245789) through Walden University to
conduct with my study using the CTN-0031A dataset. I analyzed data for 186 adults who
participated in an eight-week treatment program for cocaine and MA addiction, and who
had completed the SWCT before beginning treatment. In this study, there are four
independent variables: (a) a participant’s performance on the SWCT, (b) a participant’s
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gender, (c) a participant’s age, and (d) a participant’s race/ethnicity. There are two
dependent variables: (a) the total number of hours of treatment a participant received
during the eight-week period and (b) the differential between the number of hours of
treatment received during the first four weeks and the number of hours of treatment
received during the last four weeks. The second measure was included to address the
issue of participant attrition. Multiple regression analysis was used to examine: (a) the
relationship between the four independent variables and the first dependent variable and
(b) the relationship between the four independent variables and the second dependent
variable. The SPSS statistical software program and a NIDA codebook were utilized in
analyzing the data.
In this chapter, I provide the research hypotheses, a description of the data
collection process used in the study, the demographic characteristics of study
participants, descriptive statistics for all variables, and the results of statistical procedures
used to test the hypotheses.
Research Questions and Hypotheses
This study addressed the following research questions and hypotheses, using a
randomly selected sample of 186 addicted individuals:
Research Question 1: Does the Stroop Word Color Task (SWCT) predict the level
of participation when controlling for all other variables?
H01: The SWCT does not significantly predict the level of participation when
controlling for all other variables.
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Ha1: The SWCT significantly predicts the level of participation when controlling
for all other variables.
Research Question 2: Does gender predict the level of participation when
controlling for all other variables?
H02: Gender does not significantly predict the level of participation when
controlling for all other variables.
Ha2: Gender significantly predicts the level of participation when controlling for
all other variables.
Research Question 3: Does age predict the level of participation when controlling
for all other variables?
H03: Age does not significantly predict the level of participation when controlling
for all other variables.
Ha3: Age significantly predicts the level of participation when controlling for all
other variables.
Research Question 4: Does race/ethnicity predict the level of participation when
controlling for all other variables?
H04: Race/ethnicity does not significantly predict the level of participation when
controlling for all other variables.
Ha4: Race/ethnicity significantly predicts the level of participation when
controlling for all other variables.
Research Question 5: Does the SWCT predict the level of attrition in participation
when controlling for all other variables?
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H05: The SWCT does not significantly predict the level of attrition in
participation when controlling for all other variables.
Ha5: The SWCT significantly predicts the level of attrition in participation when
controlling for all other variables.
Research Question 6: Does gender predict the level of attrition in participation
when controlling for all other variables?
H06: Gender does not significantly predict the level of attrition in participation
when controlling for all other variables.
Ha6: Gender significantly predicts the level of attrition in participation when
controlling for all other variables
Research Question 7: Does age predict the level of attrition in participation when
controlling for all other variables?
H07: Age does not significantly predict the level of attrition in participation when

controlling for all other variables.
Ha7: Age significantly predicts the level of attrition in participation when

controlling for all other variables
Research Question 8: Does race/ethnicity predict the level of attrition in
participation when controlling for all other variables?
H08: Race/ethnicity does not significantly predict the level of attrition in
participation when controlling for all other variables.
Ha8: Race/ethnicity significantly predicts the level of attrition in participation
when controlling for all other variables.
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Data Collection
The present study utilized an archival dataset released by the Clinical Trials
Network of the National Institute on Drug Abuse. The population for the present study
were active cocaine and MA-addicted men and women of at least 18 years of age who
met all requirements as participants from the CTN-0031A study (NIDA, 2013). The
study analyzed a randomly selected sample of 186 people who (a) participated in
treatment programs offered at six community sites and (b) completed the Comalli-Kaplan
version of the SWCT. Random selection ensures that each potential participant has an
equal probability of being selected, thus confirming that study participants are
representative of the target population (Creswell, 2009). NIDA drew the sample and
provided the participant-specific data. According to calculations based on G*Power
Version 3.1.9.2, the sample of 186 made available for the present study would yield a
power level of 0.99 for an effect size of 0.30, meaning that there is a high probability of
finding a significant effect if one exists.
Description of the Participants
In this study, there were 186 participants, of which 125 (67%) were female and 61
(33%) were male (Table 1). Among participants, 21 were under the age of 21 (11.3%),
53 participants were between the ages of 21 and 29 (28.5%), 63 (33.9%) participants
were between the ages of 30 and 39, and 49 (26.3%) participants were aged 40 and above
(Table 1). Among the 186 study participants, the percentage who were non-Hispanic
white and the percentage who were non-Hispanic black was identical, 82 individuals—
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44.1%. Ten Hispanics comprised 5.4% of the participants, and 12 (6.5%) of the
participants did not disclose their race or ethnicity (Table 1).

Table 1
Demographic Characteristics of the Participants
n

Percent

Valid
percent

61

32.8

32.8

Female

125

67.2

67.2

Total

186

100.0

100.0

<21

21

11.3

11.3

21-29

53

28.5

28.5

30-39

63

33.9

33.9

40+

49

26.3

26.3

186

100.0

100.0

Non-Hispanic white

82

44.1

47.1

Non-Hispanic black

82

44.1

47.1

Hispanic

10

5.4

5.7

174

93.5

100.0

12

6.5

186

100.0

Gender
Male

Age

Total
Race/Ethnicity

Total
Missing
Total

Note: The even split between non-Hispanic white and non-Hispanic black was accidental.

Results
The demographic variables constituted three of the four independent variables
used in producing the major findings of this study. The fourth independent variable used
in the analysis was the score summarizing participants’ performance on the SWCT test.
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The summary score was calculated by subtracting the seconds required to complete
Stroop Task 1 from the seconds required to complete Stroop Task 3. The lower the
summary SWCT score for a participant, the better.
Among the 186 participants, 15.1% had a score of less than 35 seconds, 34.9%
had a score between 35 and 49 seconds, 24.7% had a score of between 50 and 64
seconds, and 25.3% had a score of at least 65 seconds (Table 2).
Table 2
Participants' Summary Score on the Stroop Word Color test
n

Percent

Valid
percent

<35 points

28

15.1

15.1

35-49

65

34.9

34.9

50-64

46

24.7

24.7

65+

47

25.3

25.3

Total

186

100.0

100.0

Note: The lower the score, the better.

The mean summary score was 53.4 seconds (Table 3). SWCT scores were
analyzed to determine how they varied according to participants’ gender, age and
race/ethnicity. The mean for male participants (N = 61) was 54.1, and the mean for
female participants (N = 125) was 53.1 (Table 3). A t-test for equality of means
confirmed that the small difference between men and women in the SWCT score was not
statistically significant (p = .723).
The mean score for white non-Hispanic participants (N = 82) was 48.3 and the
mean score for black non-Hispanic participants (N = 82) was 60.1 (Table 3).
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A t test for equality of means found that the difference between white nonHispanics and black non-Hispanics in the SWCT score was statistically significant (p =
.000). The 10 Hispanic participants had a mean score of 53.2. Because there were so
few Hispanics in the sample, they were excluded from the between-groups analysis
(Table 3).
Table 3

Means and T-Tests for Participants’ Summary Score on the Stroop Word Color test
by Gender and by Race/Ethnicity
Gender
Male
Female
Overall
T-Test, p = .723

n

Race/Ethnicity
White non-Hispanic
Black non-Hispanic
Hispanic--white or black
Overall
Note: Missing=12

n

61
125
186

Mean
54.11
53.06
53.4

SD
18.657
19.288
19.039

82
82
10
174

Mean
48.27
60.12
53.2
54.14

SD
15.927
20.847
16.109
19.212

T-Test between white non-Hispanic and black non-Hispanic, p = .000.

As for the age variable, a Pearson correlation coefficient analysis and an
accompanying scatterplot (Figure 1) showed a statistically significant inverse relationship
between age and SWCT score (r (185) = -.158, p = .032). That result means older
participants tended to have a lower (or better) SWCT score than did younger participants.
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Figure 1.
Relationship Between Participant’s Age and Participant’s SWCT Score

A Pearson correlation coefficient analysis and an accompanying scatterplot
(Figure 2) showed a slight positive relationship between a participant’s SWCT score and
the total number of hours of treatment that the participant received, but the correlation
was found not to be statistically significant (r(185) = .005, p = .941).
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Figure 2.
Relationship Between Participant’s SWCT Score and Participant’s Total Treatment
Hours

The mean number of total treatment hours received by a participant was 33.9
(Table 4). The level of treatment hours received was analyzed to determine how
treatment hours varied according to participants’ gender, age and race/ethnicity. The
mean for male participants (N = 61) was 26.0, and the mean for female participants
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(N = 125) was 37.7 (Table 4). A t-test for equality of means found that the difference
between men and women in total treatment hours was statistically significant (p =.004)
(Table 4). The mean number of total treatment hours for white non-Hispanic participants
(N = 82) was 32.4 and the mean score for black non-Hispanic participants
(N = 82) was 36.5. A t-test for equality of means found that the difference between white
non-Hispanics and black non-Hispanics in total treatment hours was not statistically
significant (p = .340). The 10 Hispanic participants had a mean score of 24.2. Given the
low number of Hispanics in the sample, they were excluded from the between-groups
analysis (Table 4).
Table 4

Means and T-Tests for Participants’ Total Treatment Hours
by Gender and by Race/Ethnicity
Gender
Male
Female
Overall
T-Test, p = .004

n

Race/Ethnicity
White non-Hispanic
Black non-Hispanic
Hispanic--white or black
Overall
Note: Missing=12

n

Mean
61
125
186

25.956
37.745
33.878

Mean
82
82
10
174

32.404
36.485
24.15
33.853

SD

28.9607
24.6042
26.6191

SD

24.8603
29.5342
19.3578
26.9628

T-Test between white non-Hispanic and black non-Hispanic, p = .340.
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As for the age variable, a Pearson correlation coefficient analysis and an
accompanying scatterplot (Figure 3) showed no correlation between age and total
treatment hours (r(185) = -.005, p = .941).

Figure 3.
Relationship Between Participant’s Age and Participant’s Total Treatment Hours

A Pearson correlation coefficient analysis and an accompanying scatterplot
(Figure 4) showed no correlation between a participant’s SWCT score and the extent of
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attrition in treatment. The extent of attrition was calculated by subtracting the number of
hours of treatment received during the last four weeks of the program from the number of
hours of treatment received during the first four weeks of the program (r(185) = -.009, p
= .902).
Figure 4
SWCT Score and the Extent of Attrition in Treatment
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The mean number of treatment hours that participants received in the last half of the
program compared with the first half was - 6.2 hours (Table 5). The differential in
treatment hours between the last half and the first half was analyzed to determine how
attrition varied according to participants’ gender, age, and race/ethnicity. The mean for
male participants (N = 61) was - 3.3 hours, and the mean for female participants
(N = 125) was -7.6 hours (Table 5). A t-test for equality of means found that the
difference between men and women in the extent of attrition was statistically significant
(p = .004) (Table 5). That result means that as the treatment program progressed, women
reduced their participation more than men. The mean number of treatment hours that
participants received in the last half of the program compared with the first half was -7.1
for white non-Hispanic participants (N = 82) and 6.1 for black non-Hispanic participants
(N = 82) (Table 5). A t-test for equality of means found that the difference between white
non-Hispanics and black non-Hispanics in attrition was not statistically significant
(p = .486) (Table 5). The 10 Hispanic participants had a mean of -0.3 hours on the
attrition measure. Because there were so few Hispanics in the sample, they were
excluded from the between-groups analysis.
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Table 5

Means and T-Tests for Participants’ Treatment Hours
in the Last 4 Weeks Minus Treatment Hours in the First 4 Weeks
by Gender and by Race/Ethnicity
Gender
Male
Female
Overall
T-Test, p = .004

n

Race/Ethnicity
White non-Hispanic
Black non-Hispanic
Hispanic--white or black
Overall
Note: Missing=12

n

Mean
61
125
186

-3.344
-7.574
-6.187

Mean
82
82
10
174

-7.09
-6.118
-0.28
-6.241

SD

6.4023
10.5433
9.5794

SD

9.0095
8.815
12.2414
9.197

T-Test between white non-Hispanic and black non-Hispanic, p = .486.
As for the age variable, a Pearson correlation coefficient analysis and an
accompanying scatterplot (Figure 5) showed that older participants reduced their
participation more than younger participants, but the correlation was found not to be
statistically significant (r(185) = -.118, p = .108).
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Figure 5.
Relationship Between Participant’s Age and the Extent of Attrition in Treatment

Variables Used in Regression Analysis
This study addressed eight hypotheses, using multiple regression analysis to test
four of the hypotheses and another multiple regression analysis to test the other four
hypotheses. The same four independent variables are used in each multiple regression:
the participant’s SWCT score, the participant’s gender, the participant’s age, and the
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participant’s race/ethnicity. Dummy variables were constructed to permit use of the
nominal-level variables of gender and race/ethnicity. In one multiple regression, the
dependent variable is the participant’s total number of treatment hours received. In the
other multiple regression, the dependent variable is the number of treatment hours that a
participant received in the last half of the program minus the number of hours received in
the first half. In each regression, the independent variables were entered into the model
simultaneously. Thus, all four hypotheses addressed in a regression were tested
simultaneously.
Assumptions for Regression Analysis
The data collected for this study satisfy all eight assumptions required for the use
of multiple regression analysis. The first assumption is that a regression has one
dependent variable and that the dependent variable is continuous measure. In this study,
two regressions were performed. The dependent variable in the first regression was the
number of hours of treatment received during the eight-week period. The dependent
variable in the second regression was the difference between the number of hours of
treatment received during the first four weeks and the number of hours of treatment
received during the last four weeks. The second assumption is that a multiple regression
has at least two independent variables. In each of the regressions used in this study, four
independent variables were used: the participant’s score on the SWCT, the participant’s
gender, the participant’s age, and the participant’s race/ethnicity.
The SWCT score and the participant’s age are continuous-measure variables.
Dummy variables were created to represent gender and race/ethnicity. The third
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assumption is that there is no multicollinearity among the independent variables used in
the regression. The correlation matrix in Table 6 shows that there is little correlation
between the independent variables.

Table 6

Pearson Product-Moment Correlation Coefficients
Between Independent Variables Used in the Two Regression Analyses
Variable

Stroop

Age

Gender

Race

--

-.158

-.026

-.289

Age

-.158

--

.200

.253

Gender

-.026

.200

--

.152

Race

-.289

.253

.152

--

Stroop score

The fourth assumption is that there is independence of residuals. Testing that
assumption was accomplished by (a) performing a regression procedure that yielded
unstandardized predicted values, studentized residuals, studentized deleted residuals,
Cook’s Distance values, and leverage values, and (b) using the Durbin-Watson Statistic.
For the total-treatment-hours variable, the Durbin-Watson level was 2.040, indicating
independence of residuals. For the variable measuring attrition, the Durbin-Watson level
was 2.016, indicating independence of residuals (Table 7).
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Table 7

Summary of Durbin-Watson Statistics
Variable

Durbin-Watson Statistic

Total treatment hours

2.040

Difference between
hours for weeks 1-4 and
hours for weeks 5-8

2.016

The fifth assumption, linearity, was tested by producing partial regression plots
addressing the relationship between the dependent variable and each of the continuousmeasure independent variables in the two regression analyses. The partial regression
plots demonstrated linear relationships (Figures 6a, 6b, 7a, and 7b).
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Figure 6a.
Partial regression plot of total treatment hours with Stroop test score
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Figure 6b.
Partial regression plot of total treatment hours with age of participant
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Figure 7a.
Partial regression plot of change in treatment hours with Stroop test score
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Figure 7b.
Partial regression plot of change in treatment hours with age of participant
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The sixth assumption, homoscedasticity, was tested through the plotting of
studentized residuals against the unstandardized predicted values in the two regression
analyses. The shape of the residuals observed in the plots confirms homoscedasticity
(Figures 8 and 9).

Figure 8.
Homoscedasticity plot for total treatment hours
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Figure 9.
Homoscedasticity plot for change in treatment hours

The seventh assumption is that no significant outlier values exist in the data set.
Standardized residuals were calculated for each case for each regression, as were values
for leverage and Cook’s Distance. No troublesome outliers were found. The eighth
assumption is that the residuals are normally distributed. Histograms and P-P Plots
indicate that the standardized residuals for each regression are approximately normally
distributed (Figures 10a, 10b, 11a and 11b).
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Figure 10a.
Frequency distribution of the regression standardized residual for total treatment hours.
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Figure 10b.
Frequency distribution of the regression standardized residual for change in treatment
hours.
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Figure 11a.
Normal P-P Plot of the regression standardized residual for total treatment hours.
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Figure 11b.
Normal P-P Plot of the regression standardized residual for change in treatment hours.
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Results of Regression Analysis
The first four hypotheses tested were:
1. The SWCT predicts the level of attendance when controlling for all other
variables.
2. Gender predicts the level of attendance when controlling for all other variables.
3. Age predicts the level of attendance when controlling for all other variables.
4. Race/ethnicity predicts the level of attendance when controlling for all other
variables.
The regression output displayed in Table 8 shows that gender is a statistically
significant predictor of participation (Adjusted R2 = .029, F(4, 169)=2.292, p<.01), thus
providing support for Hypothesis 2. Although gender is a statistically significant
predictor, it still explains only 2.9% of the variation in level of attendance. The
unstandardized beta coefficient for the dummy variable “female” is positive (12.420),
indicating that a female participant would tend to receive more treatment hours than
would a male participant. The regression analysis found that none of the other
independent variables improved the ability to predict the level of attendance. Therefore
Hypotheses 1, 3 and 4 were not supported.

108

Table 8
Summary of Multiple Regression Analysis for Participants' Total Hours of Treatment
B
27.109
12.420
-3.311
-0.107
.067

SE B
10.503
4.352
4.353
0.238
.110

β
-.220
-.061
-.035
.048

t
2.581
2.854
-0.761
-0.448
.610

p
.011
.005**
.448
.655
.543

Intercept
Participant is female
Participant is white
Participant's age
Participant's Stroop score
Note 1: **p <.01.
Note 2: B =unstandardized regression coefficient; SE B =standard error of the coefficient;
β =standardized coefficient; t =values.

The final four hypotheses tested were:
5. The SWCT predicts the level of attrition in participation when controlling for all
other variables.
6. Gender predicts the level of attrition in participation when controlling for all other
variables.
7. Age predicts the level of attrition in participation when controlling for all other
variables.
8. Race/ethnicity predicts the level of attrition in participation when controlling for
all other variables.
The regression output displayed in Table 9 shows that gender is a statistically
significant predictor of attrition in drug treatment participation (Adjusted R 2 = .039, F(4,
169) = 2.737, p<.01), thus providing support for Hypothesis 6.
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Although gender is a statistically significant predictor, it still explains only 3.9%
of the variation in participation attrition. The unstandardized beta coefficient for the
dummy variable “female” is negative (-3.997), indicating that a female participant would
tend to experience more of a drop-off in participation than would a male participant. The
regression analysis found that none of the other independent variables improved the
ability to predict the level of attendance, thus Hypotheses 5, 7 and 8 were not supported.

Table 9
Summary of Multiple Regression Analysis for Participants' Attrition in Treatment
B
-.068
-3.997
.782
-.080
-.010

SE B
3.565
1.477
1.477
.081
.037

β
--.207
-.043
-.078
-.022

t
-0.019
-2.706
-0.529
-0.994
-.280

p
.985
.008**
.597
.322
.780

Intercept
Participant is female
Participant is white
Participant's age
Participant's Stroop score
Note 1: **p<.01.
Note 2: B =unstandardized regression coefficient; SE B =standard error of the coefficient;
β =standardized coefficient; t =values.
Note 3: A negative coefficient indicates attrition.

Summary
In Chapter 4, I analyzed data using an archival drug treatment program study that
included the demographic characteristics of 186 adults who participated in an eight-week
treatment program for cocaine and MA addiction. My study also included an analysis of
participants’ performance on the Stroop Word Color Task completed before beginning
treatment. Next, I reported the number of hours of treatment that participants received,
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broken down by number of hours in the first four weeks of the program and number of
hours in the final four weeks. In addition, I described results of an analysis examining
the relationship between (a) the participants’ treatment program participation, and (b) the
participants’ demographic characteristics and SWCT test performance. The analysis
found that in the eight-week treatment program women tended to participate more than
men but that the level of attendance in the program did not vary significantly by age,
race/ethnicity, or SWCT score. The analysis also found that women tended to experience
more of a participation drop-off than men as the treatment program progressed, but that
participants’ attrition did not vary significantly by age, race/ethnicity, or SWCT score.
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Chapter 5: Discussion
Neuropsychological studies of neurocognitive deficits related to cocaine and MA
abuse have demonstrated that addiction vulnerabilities, treatment, and relapse differ by
sex (Becker, McClellan, & Reed, 2017; Ramackers et al., 2016). Contemporary drug
addiction theories are heavily based in classical and operant conditioning paradigms
(Becker et al., 2017). These theories underscore two significant factors of drug addiction:
(a) brain-based behaviors in addiction are contingent upon rewards systems associated
with positive or negative reinforcement, and (b) that neurocognitive behaviors in
addiction conditioning can differ by sex (Mitchell & Potenza, 2015).
This quantitative, correlational study was designed to examine whether the level
of attendance and level of attrition of cocaine and MA-addicted adult males and females
in a drug treatment program is associated with a participant’s demographic
characteristics. In addition, I explored the association between levels of treatment
attendance and performance on a test of neurocognitive function. The dependent
variables in this study were the total number of hours of treatment a participant received
during an eight-week drug treatment period, the difference between the number of hours
of treatment received during the first four weeks, and the number of hours during the last
four weeks. The second measure (differential number of hours between first four and last
four weeks) was included to address the issue of participant attrition.
Participants in this study were randomly selected from an archival study involving
drug treatment community sites across the United States (NIDA, 2013). All participants
met the archival study requirements. All study participants were active cocaine and
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methamphetamine-addicted individuals. All participants were at least 18 years of age at
the time of the archival study. All study participants had completed a series of tests of
neurocognitive function including the Stroop Word Color Task (SWCT).
I conducted a multiple regression analysis to determine whether a participant’s
gender, age, race/ethnicity, and performance on the SWCT was related to hours and
weeks spent in a specific drug treatment program, and non-completion hours while
enrolled in treatment. In terms of demographic characteristics, gender was a statistically
significant predictor of number of hours spent in a drug treatment program. In addition,
gender was statistically significant in measuring completion of the eight-week treatment
program.
I found that while women typically participated more than men in the first four
weeks of a drug treatment program, women were more likely to have higher noncompletion (or attrition rates) than did men in the last four weeks. The findings in this
study concerning gender differences in levels of treatment attendance are supported by
previous research involving environmental, social, and psychological factors that often
hinder successful drug treatment participation (CBHSQ, 2015; Hartwell, 2016).
In addition, neuropsychological researchers reported that complications of female
cocaine and MA addiction involve multiple brain pathways that serve to interrupt, modify
and severely damage cognition and executive functions (Simpson et al., 2016). Studies
of treatment attrition and relapse substantiate that females exhibit greater enhancement of
dopamine systems during initial drug exposure than men. This effect on the dopamine
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system is expected to impact a woman’s ability to maintain drug abstinence after
treatment (Shrestha et al., 2015).
In this study I found that older participants tended to have a lower (or better)
score on the SWCT than did younger participants. In addition, I found no significant
differences in terms of age, race/ethnicity, or SWCT score of a participant.
Interpretation of the Findings
Data specific to participants’ age and race/ethnicity were extracted from the
general demographic questionnaire section of CTN-0031A. Any specific identifiers
including names, location, incarcerations and other personal identifiers were eliminated
from the CTN-0031 and CTN-0031A dataset files. The SWCT is one of the most reliable
and widely used neuropsychological tests of executive function involving selective
attention, cognitive control and flexibility, goal-oriented behavior, and impulsivity
(Kiyonaga & Enger, 2014). In addition, the SWCT has been deemed very useful in
detecting cognitive impairments due to chemical changes in the brain related to substance
abuse. In this study, it was expected that participants would demonstrate greater
cognitive interference in response time performance of executive function based on
comparable studies that employed SWCT testing.
Although other neuropsychological were tests administered in the archival study,
the documented reliability and validity of the SWCT was considered most relevant for
this research. Participants who completed the SWCT did so voluntarily and met rigorous
APA regulations and policy regarding ethics and standards in testing substance abusing
populations. Testing bias and undue influence in using the SWCT were resolved in the
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archival study. Despite these circumstances, this does not diminish the need for
continued drug addiction intervention especially among these largely underserved groups
(Burlew, 2018).
Regarding the relationship between performance on the SWCT and the level of
attendance when controlling for all other variables, the results indicate no significant
relationship between these two variables. Regarding the relationship between
performance on the SWCT and the level of attrition when controlling for other variables,
the results indicate no correlation between a participant’s score and extent of attrition in
treatment.
In terms of the relationship between age and the SWCT score, the results showed
an inverse relationship, meaning that older participants tended to have lower (better)
SWCT scores than did younger participants. Over two-thirds of the participants in this
study were between the ages of 18 and 39 years old, the remaining participants were age
forty or older. In this study, eleven percent of participants were between the ages of
eighteen and twenty years old. Although this study did not take as a focus drug addiction
experiences of young adults (ages eighteen to twenty-one), addiction among this group
presents special challenges (Reynolds. Basso, Miller, Whiteside, & Combs, 2019).
Among these complications are problems in coping with social and emotional
traumas including physical or sexual abuse in childhood, a history of parental abuse of
alcohol or drugs, depression and anxiety, and social isolation (Reynolds et al., 2019).
The diversity of social circumstances of young adults who become addicted often leads to
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negative consequences including higher school drop-out rates, lower employment,
homelessness, and incarceration. Santa Maria, Narendorf, & Matthew (2018) revealed
that substance abuse in general among young adults often involved a disproportionate
number of homeless and incarcerated youth. In their study they concluded that substance
abuse was correlated with race/ethnicity, gender, sexual identity, shelter status, stress and
trauma.
In this type of research, these results are not atypical in that drug addiction
studies related to SWCT performance demonstrated that those who fall into the young
adult age group are more likely to experience problems with interference control and
inhibition in neurocognitive tests than older participants (Dahlgren et al., 2016; Portugal
et al., 2018). Regarding the relationship between the number of treatment hours and
gender, the results indicate that the difference between men and women in total treatment
hours was statistically significant. In viewing race/ethnicity and total treatment hours, the
results indicate that the difference between white non-Hispanics and black Non-Hispanics
was not statistically significant. In my study, the number of white and black participants
were evenly split, and the numbers of Hispanic and other participants were low (less than
10%). Although the archival study sites were in urban areas, with higher percentages of
Latina and other ethnic minorities, the absence of these groups in drug addiction studies
are not uncommon. Based on current drug addiction studies, while the incidence of drug
use and substance abuse are endemic in many of these communities; cultural differences,
a general lack of distrust of substance abuse professionals, current legal or citizenship
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status, and fear of retribution often contribute to a lack of participation in drug abuse
treatment programs (Burlew, 2018; Greenfield, Roos, Hagler, Stein, Bowen &
Witkiewitz, 2018). I want to stress that these factors should not deter comprehensive and
informed outreach for future addiction research and treatment program services for these
groups.
The mean number of treatment hours between the first half and the last half was
analyzed to determine how attrition varied according to the participants’ gender, age, race
and ethnicity. The results indicate that the difference between addicted men and addicted
women in the extent of attrition was statistically significant. The result indicates that as
the treatment program progressed, women reduced their participation more than men.
There was no statistically significant difference between white non-Hispanics and
black non-Hispanics in attrition, that is the mean number of treatment hours that
participants received in the last half of the program compared with the first half. As for
the age variable, the results indicate that older participants reduced their participation
more than younger participants, but the correlation was not found to be statistically
significant.
Limitations of the Study
The type of correlational design for this study does not offer strong internal
validity for several reasons: (a) the sample size of 186 participants was quite modest, (b)
the representation of 61 males was smaller than number of female participants, and (c)
participants were active cocaine and/or methamphetamine addicts. These factors
presented certain challenges in my ability to generalize findings to other substance
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addicted groups in the general population. These data were extracted from previous
research that focused on treatment attendance and attrition among active cocaine and
methamphetamine-addicted men and women. Given that the dataset was archival,
participant selection, drug history, personal profiles, and any number of social and
psychological factors that might have influenced their participation in the selected drug
treatment program are beyond the control of this researcher. In addition, the reliability of
testing actively addicted cocaine and MA-addicted men and women presents special
challenges in terms of validity and reliability of collected self-reports and actual test
performance.
Protection of participants’ rights, and privacy prevented access to any identifying
information that might have shed light on previous drug treatment enrollment,
performance on prior neuropsychological tests and a participant’s environmental
dynamics. Any combination of these factors might have influenced a participant’s
success or attrition in a drug treatment program. In the archival study, six psychometric
tests were administered, whereas in this study scores from only the SWCT were used,
leaving open the possibility that one or more tests (not included in my study) might have
demonstrated an association between a participant’s test performance and treatment
attendance.
Recommendations
Clinical psychology literature strongly supports therapeutic drug treatment
programs in alleviating substance dependence; however, it is reported that fewer than half
of participants complete recommended programs (Worhunsky et al., 2013). Female
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participants with low attendance or high incompletion rates during active drug treatment
are more likely to return to substance abuse than program completers (FernandezMontalvo et al., 2017). Neuropsychological studies contend that although there are
commonalities in the neural pathways to drug addiction regardless of sex, there are
significant differences in the attributes of social environment, physical, and physiological
elements between males and females. Psychological models of addiction based on
classical learning theories assert that female addicts experience addiction differently in
terms of persistence of use and rationale for continuing substance abuse despite the very
serious, and dangerous consequences to themselves and others.
The realities of the persistence of drug addiction offer plentiful opportunities to
further examine the lived experiences of women who abuse cocaine, methamphetamine,
and other illicit drugs (Imtiaz, Wells, & McDonald, 2016). Researchers and practitioners
must continue to focus on the complexities of substance abuse that affect the participation
of women in drug treatment programs, and on the need to more accurately assess
environmental, physical, and psychological limitations that are often placed on female
addicts before, during and after treatment. Researchers must also find ways to expand the
relevance of gender-based studies in neurocognition and substance use research.
Removing biased language, providing a means of safety and greater inclusiveness of
women in addiction studies are important factors in eliminating societal stigmas for
addicted women.
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Implications
Substance-abusing women are a unique group in that they are often difficult to
identify, locate and evaluate for drug treatment. Drug treatment programs and
posttreatment recovery must include strategies that are cognizant of past and present life
circumstances, and other special issues that are likely to hinder seeking treatment and
successful drug recovery. Treatment protocols must include evaluation and assessment
of life circumstances that include social, physical and psychosocial events that
encourages women to seek treatment, and to continue participation in treatment
programs. While health risks, social dysfunction, and incarcerations rates are increasing
for many addicted women, the availability of appropriate treatment programs, peer
support and mentoring, and financial assistance have not kept pace (Lorvick, Browne,
Lambdin, & Comfort, 2018).
To become a drug addict is seldom the outcome that any woman desires for her
life regardless of the circumstance of her addiction; likewise, addiction recovery (if even
possible) is often fragile and temporary even under the best conditions. To be clear, it is
erroneous to conclude that substance abusing women fit any particular social category,
they do not; nor do all addicted women share similar life experiences. The diversity of
these experiences including their roles and statuses in society, whether prominent or
obscure, can also present special challenges for cocaine and MA-addicted females. Some
of these challenges involve availability and access to needed resources including
financial and medical assistance, and on-going social support networks. Additional
psychological research on female addiction and recovery must be supported in terms of
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greater access to study populations and general outreach. Researchers should actively
engage as change agents in terms of working with other professionals to promote
awareness, provide early intervention, and secure the tools required for recovery and
restorative health for at-risk and drug addicted women.
Conclusion
Neurocognitive studies involving tests of executive function reveal that while
cocaine and MA-addicted males and females exhibit similar problems in working
memory and decision-making tasks, stark differences between addicted males and
females emerge in tests of impulsivity (Moeller, 2014). In executive function tests,
females were more likely to demonstrate highly impulsive behaviors in responding to
drug use events compared with males. These impulsivity responses are also related to the
likelihood of how females respond to drug treatment participation and completion
(Balconi et al., 2015; Jaskina et al., 2014). In developing addiction treatment plans, the
importance of neurocognitive behaviors related to decision-making, impulsivity, risk
taking and inhibitory mechanisms in females must be made relevant in terms of
rehabilitative strategies.
Conducting pertinent psychological tests to assess executive function performance
can provide further insight in predicting treatment participation and treatment attrition of
substance-abusing females. One such test is the SWCT, a neuropsychological test used
extensively in evaluating cognitive interference related to executive function in drug
addiction (Scarpina & Tagini, 2017). This study endeavors to add to existing knowledge
by: (a) comparing how cocaine and MA-addicted people differ by gender in their level of
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participation in a treatment program; and (b) whether a person’s degree of executivefunction impairment is correlated with the person’s level of participation in a treatment
program.
It is anticipated that this study will encourage neuropsychological researchers to
more rigorously explore how specific brain-based behaviors among female addicts shapes
their ability to successfully participate in drug treatment programs. Increasing the
participation of adult female addicts (including incarcerated populations) in female
inclusive studies is critical in understanding the challenges of addiction and plausible
solutions. The implication in this study for positive social change includes disrupting
gendered stigmas and life-threatening vulnerabilities that impede help for drug-addicted
women (Keane, 2017).
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